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CHAPTER I 
 
 
INTRODUCTION 
 
 
Serotonin 
 
The monoamine neurotransmitter serotonin (5-hydroxytryptamine; 5HT) 
modulates a wide variety of behaviors including appetite, locomotion, sexual behavior, 
nociception, sleep, drug abuse and hallucinations (Dubovsky and Thomas, 1995; 
Pandey et al., 1995). Serotonergic neurons are among the first neurons to be generated 
in mammalian development, with release of 5HT occurring before other synapses are 
established (Gaspar et al., 2003). 5HT-containing cell bodies and dendrites are located 
in the raphe nuclei of the brainstem and are contained within the B1-B9 cell groups 
(Dahlstrom and Fuxe, 1964). B1-B5 form the caudal division and project to the spinal 
cord while B6-B9 form the rostral division and project to forebrain regions (Figure 1) 
(Lidov and Molliver, 1982; Wallace and Lauder, 1983).  
 
 
Figure 1: Major serotonergic pathways in the rodent brain. Serotonergic neurons are 
located in the raphe nuclei in the brainstem. Projections into the spinal cord terminate in 
the dorsal horn and are important in pain sensation while forward projections run into the 
medial forebrain bundle and terminate forebrain regions. 
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These neurons are formed early in development, on embryonic days (E) 10-12 in 
mouse, and within the first month of development in primates (Levitt and Rakic, 1982). In 
cultures of raphe neurons, 5HT increases axon outgrowth and may inhibit other neuronal 
precursors from differentiating into serotonergic neurons (De Vitry et al., 1986; Whitaker-
Azmitia and Azmitia, 1989). Given the existence of multiple distinct 5HT receptor 
subtypes, it is thought that each receptor has a limited set of actions during specific 
periods in development (Gaspar et al., 2003). In developing mouse embryos, 5HT 
appears to act in a dose-dependent manner, regulating activation of specific 5HT 
receptor subtypes (Lauder et al., 2000). Since 5HT is released from nerve terminals in 
virtually all regions in the CNS, the serotonergic system is implicated in nearly all 
physiological functions and thus, perturbations of this system may be responsible for the 
pathogenesis of several diseases including hypertension, hormonal dysfunction, 
depression, anxiety, and migraine (Fink and Gothert, 2007).  
 
5HT receptors 
 
Molecular, physiological and pharmacological studies have provided evidence for 
at least fourteen distinct 5HT receptor subtypes which have been classified into seven 
families (5HT1-5HT7) based on genomic structure, amino acid sequence similarities, 
relative ligand binding affinities and ability to couple to specific signal transduction 
pathways (Hoyer et al., 1994) (Figure 2).  
Each of these families, with the exception of the 5HT3 family, belongs to a larger 
family of seven transmembrane-spanning, G-protein-coupled receptors (GPCRs) with a 
carboxyl terminus oriented towards the cytoplasm and an amino terminus oriented 
extracellularly; the 5HT3 receptor is not a GPCR, but rather a ligand-gated ion channel. 
The GPCRs contain 3 extracellular domains (e1-e3) which may be glycosolated, and 
contain cysteine residues that may form disulfide bonds to provide structural 
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conformation of the G-protein (Raymond et al., 2001). Three intracellular domains (i1-i3) 
contain sites for phosphorylation by serine-threonine kinases as well as sites for 
interactions with other G-proteins (Raymond et al., 2001). Neurotransmitter binding 
alters the conformation of the receptor and exposes a binding site for the α-subunit of 
the interacting heterotrimeric G-protein complex, thus triggering a GTP-GDP exchange 
that leads to the dissociation of the α subunit from the βγ complex of the heterotrimer 
and propagating signal transduction. 
 
 
 
Figure 2: 5HT receptor family. There are at least 14 distinct 5HT receptors that have 
been classified into 7 families based on sequence homology, ligand affinities and 
coupling to signal transduction pathways. 
 
5HT1 receptors 
 
 The 5HT1 class of receptors includes 5 members: 5HT1A, 5HT1B (formally 5HT1Dβ), 
5HT1D (formally 5HT1Dα), 5HT1E and 5HT1F (formally 5HT1Eβ, 5HT6). All members of this 
family couple to Gi/Go messenger systems, inhibiting adenylyl cyclase activity thereby 
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decreasing levels of cAMP. The genes encoding these receptors are all intronless and 
thus alternatively spliced isoforms do not exist. 5HT1A receptors have the highest density 
in limbic areas in the brain (Lanfumey and Hamon, 2004); 5HT1A autoreceptors are 
localized in cell bodies and dendrites of 5HT neurons of the dorsal and median raphe 
nuclei and are thought to be important for selective serotonin reuptake inhibitor (SSRI) 
mechanism of action (Riad et al., 2000; Sotelo et al., 1990). 5HT1A receptors are also 
expressed post-synaptically where they can inhibit neuronal firing through the activation 
of G-protein-gated inwardly rectifying potassium (GIRK) and Ca2+ channels (Andrade et 
al., 1986; Oleskevich, 1995; Sodickson and Bean, 1998). 5HT1A receptors are thought to 
play a role in neuroendocrine function and thermoregulation (Goodwin et al., 1985; 
Goodwin et al., 1987), sexual behavior (Ahlenius and Larsson, 1989; Maswood et al., 
1998), memory (Edagawa et al., 1998), depression and anxiety (Blier et al., 1997; Parks 
et al., 1998) and migraine therapy (Leone et al., 1998). 5HT1B receptors are expressed in 
the CNS with greatest levels of expression observed in basal ganglia and frontal cortex 
(Bennett-Clarke et al., 1993; Boschert et al., 1994). 5HT1B receptors are thought to play 
a role in pathophysiology of obsessive-compulsive disorder, addiction and depression 
(Gingrich and Hen, 2001). 5HT1D receptors are expressed at lower levels than 5HT1B 
receptors and have been found in dorsal raphe, caudate and cortex as well as in the 
human heart (Bruinvels et al., 1994; Bruinvels et al., 1993). Historically, it has been 
difficult to discern their separate functions due to the lack of drugs that can specifically 
target 5HT1B receptors over 5HT1D receptors (Hoyer and Middlemiss, 1989) but 5HT1D 
receptors are thought to be expressed on the terminals of 5HT neurons where they can 
serve as autoreceptors and also on other neuronal terminals (dopamine (DA), γ-
aminobutyric acid (GABA), glutamate) where they can inhibit neurotransmitter release 
(Pauwels, 1997; Riad et al., 2000). 5HT1E receptors were first discovered in binding 
homogenates of human frontal cortex (Leonhardt et al., 1989), but subsequent studies 
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have not been able to elucidate their functional role due to the lack of specific 
pharmacological agents. The same is also true of 5HT1F receptors, but within the CNS, 
they are concentrated in raphe, hippocampus, cortex, striatum, thalamus and 
hypothalamus (Adham et al., 1993). 
 
5HT3 receptors 
 
5HT3 receptors (formally M) have been classified as a ligand-gated ion channel 
based on electrophysiological features and sequence (Boess and Martin, 1994). These 
receptors are found on neurons in both the CNS and PNS. Within the CNS, 5HT3 
receptors are present in hippocampus (CA1 pyramidal cell region), dorsal motor nucleus 
of the solitary tract and the area postrema (Laporte et al., 1992); within the PNS, they 
are located on sensory neurons and pre- and post-ganglionic autonomic neurons. This 
receptor subclass is thought to regulate gastrointestinal motility and intestinal secretion 
(De Ponti and Tonini, 2001). 
 
5HT4 receptors 
 
5HT4 receptors couple to Gs to stimulate adenylyl cyclase activity and are mainly 
present in hypothalamus, nucleus accumbens, amygdala, basal ganglia and 
hippocampus (Medhurst et al., 2001; Vilaro et al., 2002). While only one subtype of this 
receptor is known, there are at least 10 differentially distributed, functional splice variants 
in humans with alternative C-terminal domains (Blondel et al., 1998; Blondel et al., 1997; 
Claeysen et al., 1997; Claeysen et al., 1999). Indirect evidence suggests that 5HT4 
receptors are localized post-synaptically but may also be present on terminals of other 
neurons where they can regulate neurotransmitter (DA, 5HT, GABA, ACh) release and 
enhance synaptic transmission (Bockaert et al., 2004). Activation of 5HT4 receptors 
produces a long-lasting inhibition of voltage-gated K+ channels, including Ca2+-activated 
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K+ channels (Ansanay et al., 1995; Fagni et al., 1992). 5HT4 receptor agonists can 
modulate long-term potentiation (LTP) and long-term depression (LTD) to modulate the 
responses to learning, memory, reward, novelty and stress (Bockaert et al., 2004; 
Compan et al., 2004; Kemp and Manahan-Vaughan, 2004, 2005). 
 
5HT5 receptors 
 
5HT5 receptors include two family members: 5HT5A and 5HT5B. Only the 5HT5A 
receptor is found in humans; 5HT5B has been found only in rats and mice and is believed 
to be a pseudogene in humans (Erlander et al., 1993; Matthes et al., 1993; Plassat et al., 
1992; Rees et al., 1994; Wisden et al., 1993). The coupling status of this receptor is 
unknown in native neuronal tissue but cell-culture studies have shown coupling to both 
Gi/Go and Gq/11 (Noda et al., 2003). In situ hybridization studies have revealed the 
greatest level of expression in hypothalamus, hippocampus, corpus callosum and glia, 
but not in the peripheral tissues (Plassat et al., 1992; Rees et al., 1994). Their co-
localization with glial fibrillary acidic protein (GFAP) suggests mainly astrocytic 
expression (Matthes et al., 1993). 5HT5 receptors have high affinity for lysergic acid 
diethylamide (LSD) and 5-carboxyamidotryptamine (Waeber et al., 1998). 
 
5HT6 receptors 
 
5HT6 receptors couple to Gs proteins and are almost exclusively expressed in the 
CNS with high concentrations in striatum, amygdala, nucleus accumbens, hippocampus, 
cortex and olfactory tubercle (Gerard et al., 1996; Grimaldi et al., 1998; Sleight et al., 
1998). Low levels of 5HT6 receptors can be found in the adrenal gland and the stomach 
(Monsma et al., 1993; Ruat et al., 1993a). However, they are largely localized on 
GABAergic rather than 5HT neurons (Gerard et al., 1996; Sebben et al., 1994). This 
receptor subtype has high affinity for typical and atypical antipsychotics, including 
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clozapine (Meltzer et al., 2003). They may also modulate cholinergic neurons, 
suggesting a function in learning and memory, thus serving as a treatment target in 
cognitive disorders (Bourson et al., 1998; Branchek and Blackburn, 2000). Furthermore, 
5HT6 receptors have also been implicated in psychosis, anxiety, epilepsy and mood 
disorders (Ohmori et al., 2001). 
 
5HT7 receptors 
 
5HT7 receptors (formally 5HTX) also couple to Gs proteins and are mainly found 
in thalamus, hypothalamus, cortex, hippocampus and amygdala (Gustafson et al., 1996; 
Hedlund and Sutcliffe, 2004; Thomas and Hagan, 2004). This receptor is thought to play 
a role in the control of circadian rhythms, as they are expressed in the suprachiasmatic 
nucleus of the hypothalamus (Lovenberg et al., 1993). They chiefly localize to soma and 
axon terminals of GABAergic neurons. Outside the CNS, 5HT7 receptors are also found 
in intra- and extra-cranial blood vessels and meningeal tissues as well as in the 
periphery where they mediate smooth muscle relaxation in various organs (Hedlund and 
Sutcliffe, 2004). Alternative splicing of this receptor can generate at least four spliced 
isoforms, which differ in the C-terminus, but do not appear to differ in pharmacological 
properties, signal transduction or tissue distribution (Ruat et al., 1993b). 5HT7 receptors 
demonstrate high affinity for atypical antipsychotic agents and may mediate some of 
their effects (Roth, 1994). These receptors may also be involved in learning and memory 
as 5HT7 receptor knockout mice have a decrease in synaptic plasticity and contextual 
fear conditioning (Thomas and Hagan, 2004). 
 
5HT2 receptor family 
 
The 5HT2 class of receptors includes three members: 5HT2A (formerly D, 5HT2), 
5HT2B (formerly 5HT2F) and 5HT2C (formerly 5HT1C) (Hoyer et al., 1994). The 5HT2 family 
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preferentially couples to Gq/11, subsequently leading to the activation of phospholipase C 
(PLC) to increase the hydrolysis of inositol phosphates and subsequently the cytosolic 
calcium concentration by release from intracellular stores (Figure 3). While the 5HT2 
family shares 46-50% overall sequence identity, each member of the 5HT2 family has a 
distinct expression pattern. 
 
 
 
 
 
Figure 3: 5HT2 receptor family topology and coupling. The 5HT2 receptor family 
preferentially couples to Gαq to activate phospholipase C (PLC). PLC promotes the 
hydrolysis of the membrane phospholipid, phosphatidylinositol 4,5-bisphophate (PIP2) 
into diacylglycerol (DAG) and inositol 1,4,5-triphosphate (IP3). DAG activates protein 
kinase C (PKC) while IP3 binds to its intracellular receptor to promote the intracellular 
calcium (Ca2+) release.   
 
 
5HT2A receptors 
 
5HT2A receptors are widely distributed within peripheral and central tissues. 
Peripherally, they modulate contractile responses in vascular smooth muscle and play a 
role in platelet aggregation. Within the CNS, 5HT2A receptors are located within cortex, 
olfactory tubercle, nucleus accumbens, hippocampus and basal ganglia and these 
receptors are thought to be responsible for regulation and stimulation of hormone 
secretion (ACTH, cortisol, oxytocin, prolactin) (Jakab and Goldman-Rakic, 1998). 5HT2A 
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receptors also activate phospholipase A2 (PLA2) and phospholipase D (PLD) in addition 
to PLC (Raymond et al., 2001). Surprisingly, some antagonists can induce 5HT2A 
receptor desensitization and internalization both in vivo and in vitro (Roth et al., 1991; 
Sanders-Bush et al., 1990). 5HT2A receptor knockout animals have reduced inhibition in 
conflict anxiety paradigms without affecting fear-conditioned and depression-related 
behaviors (Weisstaub et al., 2006).  
 
5HT2B receptors 
 
5HT2B receptors are located primarily in the fundus of the stomach. Activation of 
5HT2B receptors leads to smooth muscle contraction. They are also present in human 
liver and kidney as well as endothelial cells of pulmonary arteries where they are 
responsible for vasorelaxation upon activation. Within the CNS, 5HT2B receptor-like 
immunoreactivity can be seen in cerebellum, lateral septum, hypothalamus and medial 
amygdala (Sanden et al., 2000; Wainscott et al., 1993). 5HT2B receptors may mediate 
anxiolytic properties in social interactions as well as hyperphagia and reduction in 
grooming frequency. 5HT2B receptors also regulate embryonic morphogenesis; 5HT2B 
receptor antagonists have been shown to interfere with cranial neural crest cell migration 
and induced their apoptosis. 5HT2B receptor knockout animals lead to embryonic and 
neonatal lethality as a result of specific heart defects (Nebigil et al., 2000). Surviving 
animals have severe ventricular hypoplasia associated with impaired proliferation of 
myocytes (Nebigil et al., 2000; Nebigil et al., 2001). 
 
5HT2C receptors 
 
5HT2C receptor expression is limited to the CNS, with the highest levels of 
expression in choroid plexus and significant expression in hippocampus, striatum, 
amygdala and hypothalamus (Pasqualetti et al., 1999; Teitler and Herrick-Davis, 1994). 
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In addition to the activation of PLC, 5HT2C receptors can activate PLA2-mediated 
arachidonic acid (AA) release, but some agonists preferentially activate PLA2 or PLC 
(Raymond et al., 2001), a property known as agonist-directed trafficking of receptor 
stimulus. This means that a single receptor subtype can couple with different efficacies 
to several downstream signaling pathways, depending on the nature of the agonist. 
Similar to the properties of 5HT2A receptors, 5HT2C receptors are down-regulated 
following chronic antagonist exposure (Van Oekelen et al., 2003), although some studies 
have suggested that only agonists and partial agonists of 5HT2C receptors have the 
ability to cause receptor down-regulation (Schlag et al., 2004).  
Using a yeast two-hybrid screen, the 5HT2C receptor has been shown to interact 
with a novel multivalent PDZ (named after three proteins: Postsynaptic density-95, 
Drosophilia Discs large and Zonula occuludens-1) protein called multi-PDZ domain 
protein (MUPP1). PDZ domain proteins play important roles in the organization and/or 
regulation of signaling events in cells. MUPP1 contains 13 PDZ domains (Ullmer et al., 
1998) and PDZ domain 10 appears to be critical for 5HT2C receptor association 
(Becamel et al., 2001; Parker et al., 2003). Interaction between MUPP1 and the 5HT2C 
receptor leads to a conformational change in MUPP1 (Becamel et al., 2001) and deletion 
of the 2C receptor PDZ recognition motif (SXV) prevents phosphorylation of the receptor 
and delays resensitization of receptor responses (Backstrom et al., 2000). When MUPP1 
and 5HT2C receptor cDNAs are transiently co-transfected into COS-7 cells, both proteins 
colocalize together and form clusters within intracellular membranes and on the cell 
surface; MUPP1 and 5HT2C receptor mRNA also display overlapping patterns of 
expression in rat brain (Becamel et al., 2001). Further studies reveal that 5HT regulated 
MUPP1 interaction with 5HT2C receptors in a dose-dependent manner and alkaline 
phosphatase treatment restored the interaction, suggesting that MUPP1 interactions with 
5HT2C receptors are dynamically regulated by phosphorylation (Parker et al., 2003). 
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5HT2C receptor-dependent modulation of neurotransmitter release 
 
Acetylcholine 
5HT2C receptors are involved in the regulation and modulation of several 
neurotransmitters including acetylcholine (ACh). The cholinergic system plays an 
important role in memory and cognition; increasing the concentration of ACh in the 
synaptic cleft is thought to be an important therapeutic target in Alzheimer’s dementia. 
Using in vivo microdialysis in the hippocampus, Zhelyazkova-Savova et al. measured 
ACh release when rats were administered an intraperitoneal dose (IP) of m-
chlorophenylpiperazine (mCPP) (Zhelyazkova-Savova et al., 1999). In mCPP-
administered animals, ACh release in the hippocampus was increased 96% over vehicle 
treated animals (Zhelyazkova-Savova et al., 1999); this increase in ACh release could 
be prevented with an IP dose of mesulergine, a 5HT2A/2C receptor antagonist. Increases 
in ACh release were only seen with systemic doses of mCPP and not local 
administration; these effects were also observed in the cortex, suggesting that the action 
of mCPP is occurring outside of the hippocampus (Zhelyazkova-Savova et al., 1999). 
Dopamine 
5HT2C receptors have been shown to control dopamine (DA) release from 
mesolimbic and mesocortical dopaminergic neurons (Di Giovanni et al., 1999). Following 
IP administration of the 5HT2C receptor inverse agonist, SB206553, basal DA release 
was increased in both the nucleus accumbens (NAc, 42%) and striatum (33%). In 
contrast, the 5HT2A receptor antagonist, SR46349B, or the mixed 5HT2A/2B/2C receptor 
antagonist, ritanserin, failed to increase DA output in either of these regions (Di Giovanni 
et al., 1999). Taken together, these results suggest that 5HT2C receptors exert a tonic 
inhibitory control on both mesolimbic and nigrostriatal dopaminergic pathways. Further 
support for this hypothesis was demonstrated by the ability of the selective 5HT2C 
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receptor agonist, RO 60-0175, to decrease DA release in NAc (26%) and this effect 
could be completely blocked by the 5HT2C receptor antagonist, SB242084 (Di Matteo et 
al., 2000a; Di Matteo et al., 2000b). 
However, since all of these drugs were administered systemically, the location of 
5HT2C receptors involved in these effects is unknown. 5HT2C receptors are found in all 
brain regions receiving projections from mesolimbic and nigrostriatal dopaminergic 
neurons (Abramowski et al., 1995; Mengod et al., 1990; Molineaux et al., 1989). Double-
labeled in situ hybridization studies revealed co-expression of 5HT2C receptor mRNA 
with glutamic acid decarboxylase (GAD) mRNA, but not with tyrosine hydroxylase (TH) 
mRNA, indicating that 5HT2C receptor expression is restricted to GABAergic neurons 
(Eberle-Wang et al., 1997).  
5HT2C receptors mediate an indirect inhibition of DA release due to inherent 
constitutive activity of this receptor. Increases in DA release in both NAc and striatum 
were detected by microdialysis in rats systemically injected with the inverse agonist 
SB206553 or antagonist SB242084 (Berg et al., 2005; De Deurwaerdere et al., 2004), 
with observed increases of DA release much greater with SB206553. The agonist RO-
0175 was able to inhibit DA release in both of these areas; SB242084 was able to 
counteract the inhibitory effects of RO-0175 as well as the potentiated release observed 
with SB206553 when co-injected (Berg et al., 2005; De Deurwaerdere et al., 2004). 
To determine if DA release within the mesolimbic system was regionally-
dependent, in vivo microdialysis experiments have been performed in the rat. Intra-
ventral tegmental area (VTA) injections of antagonist (SB242084) abolished the 
decrease in accumbal DA outflow induced by agonist (RO-0175), but did not affect the 
increase in DA outflow induced by inverse agonist (SB206553). In contrast, intra-NAc 
injections of antagonist (SB242084) blocked both agonist (RO-0175) and inverse agonist 
(SB206553)-induced changes in DA outflow. However, only intra-NAc administration of 
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SB206553, but not intra-VTA, SB206553 alone increased basal DA outflow (Navailles et 
al., 2006). These studies indicate that there are anatomical differences for the 
constitutive activity of 5HT2C receptors.  
More recently, Navailles et al. (Navailles et al., 2008) have investigated the role 
of 5HT2C receptors within the VTA and NAc to mediate cocaine-induced behavioral 
effects. Intra-VTA injections with agonist (RO-0175) at higher doses attenuated the 
increase in accumbal DA outflow induced by systemic administration of cocaine; intra-
VTA injections of antagonist (SB242084) were unable to modify these effects. Within the 
NAc, local administration of agonist (RO-0175) amplified cocaine-induced DA outflow at 
low concentrations, while inhibiting this outflow at higher doses. Intra-NAc injections of 
antagonist (SB242084) resulted in opposite effects when applied at these 
concentrations. In the NAc, but not VTA, there exists both excitatory and inhibitory 
control of cocaine-induced DA outflow, suggesting a functional balance of different 
5HT2C receptor populations within these brain regions as well as within the mesolimbic 
DA pathway (Navailles et al., 2008). 
Taken together, these studies implicate the 5HT2C receptors in the indirect 
inhibition of DA release and suggest that the constitutive activity of 5HT2C receptors 
helps to mediate these effects; inverse agonists at this receptor produce a more 
pronounced increase in basal DA release than antagonists. The inverse agonist 
properties of certain atypical antipsychotics (clozapine, olanzapine) may therefore be 
responsible for their clinically advantageous effects.  
 
Post-transcriptional regulation of the 5HT2C receptor 
 
Alternative splicing 
 The serotonin 2C receptor primary RNA transcript can be alternatively spliced to 
generate at least 3 alternative splice variants that can alter its function by changing the 
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C-terminal region of the protein. The full length cDNA (4.8 kb) is created by splicing the 
predicted exon 5 splice donor to the exon 6 splice acceptor and is referred to as RNA2, 
encoding the full-length, fully functional 458 amino acid receptor protein (Figure 4). The 
shortest of these splice variants is referred to as RNA1 (or 5HT2C-tr) and results in a 95-
nucleotide deletion from the 3' end region of exon 5 and creates a cDNA of 
approximately 4.7 kb. This deletion leads to a shift in the reading frame and a premature 
termination codon at nucleotide positions 840-842 to generate a protein with 172 amino 
acids, including 19 carboxyl-terminus amino acids that are unique (Canton et al., 1996; 
Xie et al., 1996). RNA1 has patterns of expression in rat brain regions overlapping with 
RNA2, with the choroid plexus displaying the greatest amount of RNA1 (60% of total) 
while most neuronal tissues contain about 20-30% expression of the RNA1 isoform 
(Canton et al., 1996; Xie et al., 1996). This version of the receptor displays no 5HT 
binding or phosphoinositol (PI) hydrolysis activity in NIH-3T3 fibroblasts (Canton et al., 
1996; Xie et al., 1996). Another truncated version (RNA3 or 5HT2CR-ΔCOOH) of the 
receptor results from the addition of a 90-nucleotide sequence in intron 5 and splicing 
joins this cryptic splice donor site in intron 5 with exon 6 resulting in a cDNA of 4.9 kb. 
RNA3 is found in most regions of human brain, with the highest level of expression 
observed in spinal cord; expression can also be detected in amygdala, hippocampus 
and thalamus with the relative expression of RNA3 being 10-20% of that observed for 
RNA2 (Wang et al., 2000b). RNA3 encodes a receptor protein that is also devoid of 5HT 
binding or PI hydrolysis activity in NIH-3T3 and COS-7 cells (Wang et al., 2000b). Each 
of these alternative 5'-donor splice sites are conserved between humans, mice and rats 
suggesting a possible biological significance for the generation of multiple 5HT2C 
receptor variants by alternative splicing. 
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Figure 4: Alternative splicing of 5HT2C receptor transcripts. A portion of the 5HT2C 
receptor pre-mRNA containing intron 4-exon 5-intron 5-exon 6 is shown. The editing 
sites within exon 5 are indicated (sites A-E) and the three splicing patterns leading to 
RNA1, RNA2 and RNA3 are presented. Introns are represented by dashed lines while 
exons are represented by rectangles. 
 
 
RNA editing 
Sequence comparisons of rat, mouse and human 5HT2CR genomic DNA with 
their corresponding cDNAs revealed as many as five adenosine-to-guanosine (A-to-G) 
discrepancies (Burns et al., 1997; Niswender et al., 1998; Wang et al., 2000b) in the 
5HT2C receptor transcript. A-to-G discrepancies between genomic and cDNA sequences 
are indicative of adenosine-to-inosine (A-to-I) editing events in which specific adenosine 
moieties are post-transcriptionally converted to inosine by hydrolytic deamination 
(Polson et al., 1991). These five editing sites (termed sites A-E) were predicted to alter 
amino acids 157, 159 and 161, within the putative second intracellular loop of the rat and 
mouse receptors, to generate as many as thirty-two different mRNA transcripts encoding 
twenty-four distinct protein isoforms (Figure 5). Sequence analysis of cDNAs isolated 
from dissected rat and human brains have predicted the region-specific expression of as 
many as 15 major 5HT2C receptor isoforms encoded by twenty-three distinct RNA 
species (Burns et al., 1997; Niswender et al., 1999) and analyses of 5HT2C receptor 
expression in dissected mouse brain have revealed a similar pattern of edited RNA 
isoform expression (see Chapter 2, Table 1). Since the location of the editing sites is 
downstream of the proximal RNA1 splice site, the RNA1 isoform cannot be edited while 
RNA2 and RNA3 are capable of undergoing these A-to-I modifications. 
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Figure 5: Nucleotide and predicted amino acid sequence alignment between 
mouse 5HT2C receptor genomic DNA, mRNA and cDNA. The positions of the 5 
editing sites within the nucleotide sequence are indicated by arrows. Conversion at the 
various positions results in the amino acid codon changes indicated; for example, an A 
to G substitution at the A site converts an isoleucine codon to a valine codon. 
 
 
The second intracellular loop of GPCRs plays an important role in the coupling of 
G-proteins, especially for receptors linked to Gαq (Pin et al., 1994; Wong et al., 1990). 
Recent studies have shown that RNA editing alters the selectivity of 5HT2CR:G-protein 
coupling, where the non-edited isoform (INI) can couple to Gαq, Gα13 and Gα15, while 
more extensively edited isoforms (VSV and VGV) lose the ability to couple to Gα13 and 
Gα15. The fully edited isoform (VGV), however, gains the ability to couple to Gα11 (Figure 
6) (Price et al., 2001). Comparisons of receptor function between INI and VSV and VGV 
5HT2CR isoforms revealed that all three isoforms are coupled to the activation of 
phosphoinositide (PI) hydrolysis. Analysis of 5HT dose-response curves in transfected 
NIH-3T3 cells demonstrated that serotonergic agonists were 15- and 40-fold less potent 
when acting through the edited VSV and VGV receptor isoforms, respectively, 
suggesting that edited isoforms couple less efficiently to the intracellular signaling 
machinery (Figure 7) (Burns et al., 1997; Niswender et al., 1998). In addition to the PLC-
PI pathway, the 5HT2C receptor also couples to the phospholipase A2-arachidonic acid 
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(PLA2-AA) pathway. While serotonin was found to increase AA release as well as IP 
accumulation for each edited isoform examined, the potency for 5HT to stimulate AA 
release was less for the edited VSV and VGV receptors when compared to the INI 
isoform (Berg et al., 2001).  
 
 
Figure 6: RNA editing of 5HT2C receptor transcripts. A schematic diagram of the 
predicted topology, primary amino acid sequence and editing sites within the mouse 
serotonin (5HT2C) receptor is presented. Amino acids altered by the editing of 5-HT2C 
pre-mRNA transcripts are indicated in purple, green and blue and represent sites 157, 
159 and 161, respectively. The second intracellular loop is proposed to interact with a 
variety of heterotrimeric G-proteins to activate the PLC, PLA2, PLD and MAPK effector 
systems. 
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Figure 7: 5HT potency to activate phosphoinositide hydrolysis in cultured cells 
transiently expressing human edited 5HT2C receptors. Human isoforms were 
transiently expressed in NIH-3T3 cells and the EC50 of 5HT activation was determined. 
5HT is 15- and 40-fold less potent when acting through edited VSV and VGV receptor 
isoforms, respectively. Values represent the mean±SEM; *: p<0.05, **:p<0.01. Data from 
Niswender et al., 1999. 
 
 
Studies with 5HT2C receptor have indicated that this receptor displays constitutive 
activity and therefore does not fit the simple ternary complex model for GPCRs 
(Niswender et al., 1999). This property of the 5HT2C receptor was first identified when it 
was observed that inverse agonists such as clozapine were able to reduce the basal 
level of PI hydrolysis, indicating that the receptor is able to spontaneously isomerize into 
the active receptor state (R*), thereby activating G-proteins in the absence of agonist 
(Barker et al., 1994; Grotewiel and Sanders-Bush, 1999). Competition binding studies 
using human isoforms of the 5HT2C receptor revealed a guanine nucleotide-sensitive 
high-affinity state, only observed for the INI receptor, providing direct evidence that RNA 
editing generates 5HT2C receptor isoforms that differ in G-protein coupling efficiency 
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(Figure 8) (Niswender et al., 1999), affecting both basal activity and ligand potency 
(Herrick-Davis et al., 1999). 
 
 
 
Figure 8: Constitutive activity of transiently expressed 5HT2CINI and 5HT2CVGV 
receptors. cDNAs for edited receptors were transiently expressed in COS-7 cells and 
[3H] inositol monophosphate formation was measured under basal and stimulated 
conditions. Values represent mean±SEM; *: p<0.05. Data from Niswender et al., 1999. 
 
 
RNA editing of the 5HT2C receptor may also play a role in receptor 
desensitization and trafficking of edited receptor isoforms. Using HEK293 cells, Marion 
et al. (Marion et al., 2004) have shown decreased surface receptor expression of 
isoforms with the greatest constitutive activity, namely the INI isoform. The VGV isoform 
is expressed at the cell surface under basal conditions and is rapidly internalized into 
intracellular vesicles in the presence of a 5HT2C receptor agonist. In contrast, the INI 
isoform was predominately localized to intracellular vesicles and stimulation with 5HT did 
not significantly alter this distribution. Treatment with the 5HT2C receptor inverse agonist, 
SB206553, however did result in a translocation of the INI isoform to the plasma 
membrane surface. Similar to other GPCRs, 5HT2C receptor isoforms are internalized in 
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a βarrestin2 (βarr2)-dependent manner, but the distribution of edited receptor isoforms is 
dependent on the constitutive activity of the receptor with the VGV isoform requiring 5HT 
stimulation to traffic βarr2 to the surface. 
RNA editing has also been suggested to play a role in differential responses to 
therapeutic agents. Lysergic acid diethylamide (LSD) behaves as a partial or nearly full 
agonist when acting through the INI isoform, but for the VGV isoform, LSD had an 
attenuated ability to activate the PI pathway when compared to serotonin (Backstrom et 
al., 1999) and actually blocks 5HT signaling (Niswender et al., 2001). Clozapine, an 
atypical antipsychotic used in the treatment of schizophrenia, has been shown to behave 
as an inverse agonist at the 5HT2C receptor. Inverse agonists have been demonstrated 
to have higher affinity for the inactive R form as compared to the active R* conformation 
of the receptor. Further studies have indicated that clozapine displays a significantly 
greater affinity for VGV as compared to the INI isoform (Fitzgerald et al., 1999). 
Clozapine and the typical neuroleptic, loxapine, decrease basal PI hydrolysis when 
acting through the INI isoform, but do not have this effect on the VGV isoform 
(Niswender et al., 2001).  
Tetracyclic antidepressants, such as mirtazapine and mianserin, have been 
shown to suppress constitutive activity at recombinant and native 5HT2C receptors. In 
HEK293 cells transiently co-transfected with 5HT2CRINI and Gq, Chanrion et al. (Chanrion 
et al., 2007)  have shown that mirtazapine decreased basal IP production and therefore 
constitutive activity in a concentration-dependent manner; this effect is also observed for 
mianserin but its maximal effects are less pronounced. The decrease in constitutive 
activity can be abolished by treatment with the 5HT2C receptor antagonist, SB242084. 
Prolonged treatment with these tetracyclic antidepressants also increases the cell-
surface expression of 5HT2C receptor isoforms, as well as increase 5HT-induced IP 
production. In studies of cultured cortical neurons pre-treated with mirtazapine, 5HT 
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induced transient Ca2+ release. Taken together, these results suggest that inverse 
agonists may be more beneficial therapeutically than antagonists in abolishing the 
activity of overactive (less edited) 5HT2C receptor isoforms.  
These data suggest that RNA editing could play a role in the pathophysiology of 
schizophrenia and/or depression. Recent studies have observed alterations in 5HT2C 
receptor editing are observed in patients diagnosed with schizophrenia (Sodhi et al., 
2001), and suicide victims with a history of major depression (Gurevich et al., 2002b; 
Niswender et al., 2001), suggesting that editing of the 5HT2C receptor may be involved in 
neuropsychiatric disorders and the maintenance of appropriate serotonergic tone. 
RNA editing may also be regulated by sustained changes in serotonergic 
neurotransmission. Chronic administration of fluoxetine, an SSRI, to mice leads to 
changes in RNA editing at the E, C and D sites; E and C site editing increases while D 
site editing decreases in these treated animals (Gurevich et al., 2002a). These changes 
are opposite to the editing frequencies observed in brains of patients with major 
depression, suggesting that chronic fluoxetine treatment can prevent depression-specific 
changes in 5HT2C receptor mRNA editing (Gurevich et al., 2002a). In attempts to more 
fully define the role of serotonergic neurotransmission in RNA editing, Gurevich et al. 
depleted mice of 5HT with treatment of para-chlorophenylalanine (pCPA), a potent 
irreversible inhibitor of tryptophan hydroxylase. pCPA treated animals had decreased 
expression of more fully edited (and less active isoforms) (Gurevich et al., 2002a). 
Conversely, animals treated with a 5HT2A/2C receptor agonist, (+/-)-1-(4-iodo-2,5-
dimethoxyphenyl)-2-aminopropane (DOI), increases the expression of these more edited 
isoforms (Gurevich et al., 2002a). Neither treatment altered 5HT2C receptor mRNA 
levels, indicating that RNA editing of 5HT2C receptor transcripts is the primary 
mechanism by which 5HT2C receptors can maintain their signaling properties in 
response to changes in serotonergic neurotransmission.  
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Small nucleolar RNAs and their role in 5HT2C receptor function 
 
 Small nucleolar RNAs (snoRNAs) belong to a class of non-coding RNAs that are 
localized to the nucleolus and function mainly as guide RNAs to direct site-specific 
nucleoside modifications of ribosomal RNA (rRNA) and small nuclear RNA (snRNA) 
(Cavaille et al., 1996; Filipowicz and Pogacic, 2002). Most mammalian snoRNAs are 
expressed ubiquitously, but some are expressed exclusively in the brain (Cavaille et al., 
2000; Huttenhofer et al., 2001; Rogelj and Giese, 2004). Two classes of snoRNAs, 
H/ACA box and C/D box, each have brain specific family members and are named 
based on their targets and conserved sequence motifs. 
 H/ACA box snoRNAs contain two conserved sequence motifs: a box H 
(ANANNA) nucleotide sequence and an ACA sequence at their 3' end. Their main 
function is to direct pseudouridylation, the conversion of uridine to psuedouridine, with 
the conversion site determined by the formation of a snoRNA-rRNA hybrid (Balakin 
1996). C/D box snoRNAs have two conserved terminal sequence motifs, box C 
(RUGAUGA) and box D (CUGA), with a matching set of internal sequence motifs C' and 
D'; C/D box snoRNAs direct the 2'-O-methylation of the ribose moiety in the nucleotide 
five bases upstream of the D (or D') box (Cavaille et al., 1996; Kiss-Laszlo et al., 1996). 
 Seven brain-specific snoRNAs have been cloned from mice; MBII-12, MBII-48, 
MBII-49, MBII-52, MBII-78 and MBII-85 belong to the C/D box class while MBI-36 
belongs to the H/ACA box class. MBII-13 and MBII-78 are encoded by single copy 
genes, while the remaining brain-specific snoRNAs are found in multiple copies within 
the same locus (Huttenhofer et al., 2001). In humans, HBII-13, HBII-52 and HBII-85 are 
mapped to the 15q11-q13 region, a region implicated in Prader-Willi Syndrome; HBI-36 
maps to intron 2 of the 5HT2C receptor. 
 The expression of MBI-36, MBII-48, MBII-52 and MBII-85 is not uniform within 
the brain; their expression is most prominent in hippocampus and amygdala with MBI-36 
23 
 
expressed almost exclusively in the choroid plexus while MBII-52 is absent in the 
choroid plexus (Cavaille et al., 2000). MBII-52 (as well as the human ortholog HBII-52) is 
unique in that its potential target is known; it exhibits an 18-nucleotide complementarity 
to the 5HT2C receptor in the region of the RNA editing sites (Cavaille et al., 2000) and is 
predicted to 2’-O-methylate the ribose moiety for the adenosine at the edited C-site. 
Methylation at this position has been shown to decrease the rate of ADAR-mediated 
deamination and therefore MBII-52 is predicted to represent a negative regulator of RNA 
editing at the C-site (Cavaille et al., 2000). To address a potential role for MBII-52 in the 
regulation of RNA editing, Vitali et al. (Vitali et al., 2005) revealed that expression of 
MBII-52 was able to decrease editing at the C-site (~50%) without affecting D-site editing 
(Vitali et al., 2005). 
 In addition to MBII-52’s role in the regulation of RNA editing, Kishore et al. 
(Kishore and Stamm, 2006) also showed that MBII-52 regulates alternative splicing of 
the 5HT2C receptor by binding to a silencing element within exon 5b. Additionally, MBII-
52 promotes the formation of non-edited isoforms by masking a silencer, though this 
process is editing independent; this silencing element can be weakened by RNA editing 
at the C, D and E sites (Kishore and Stamm, 2006), suggesting that the snoRNA MBII-
52, and its human ortholog HBII-52, provide another level of 5HT2C receptor regulation 
for RNA editing and splicing. 
 
 
5HT2C receptor and behavioral implications 
 
5HT2C receptors have been implicated in a variety of human neuropsychiatric and 
behavioral disorders, including depression, dysthymia, obsessive-compulsive disorder, 
anxiety, schizophrenia and sleep disturbances (Dubovsky and Thomas, 1995; Frank et 
al., 2002; Julius, 1991; Masellis et al., 1998; Pandey et al., 1995; Teitler and Herrick-
Davis, 1994). Mice lacking the 5HT2C receptor were generated by introducing a series of 
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premature stop codons within exon 6, leading to a truncated version of the receptor 
(Tecott et al., 1995). Initial characterization of these animals found that they were more 
susceptible to spontaneous epileptic seizures, which resulted in lethality in some 
animals, especially if the seizure reached the tonic-clonic stage (Tecott et al., 1995). In 
addition, 5HT2c receptor knockout (KO) mice have a 13% increase in body mass versus 
their wild-type littermates, with significantly larger fat stores (48%) due to hyperphagia 
(Tecott et al., 1995). This chronic hyperphagia leads to a maturity-onset obesity with 
increases in plasma insulin and leptin resembling Type 2 diabetes (Nonogaki et al., 
1998).  
An examination of long-term potentiation (LTP) within the hippocampus revealed 
a selective impairment of perforant path LTP with matching deficits in behavioral assays 
of dentate gyrus function (Tecott et al., 1998); 5HT2C receptor KO animals failed to 
demonstrate preference for the platform-trained quadrant in the Morris Water Maze 
suggesting that 5HT2C receptors may play a role in synaptic plasticity within the 
hippocampus (Tecott et al., 1998). Additionally, 5HT2C receptor KO animals display 
deficits in sleep; KO mice had less non-REM sleep with increased and longer bouts of 
waking as well as enhanced responses to sleep deprivation suggesting that 5HT2C 
receptors are involved in sleep regulation (Frank et al., 2002).  
To investigate the potential role of 5HT2C receptor and the regulation of cocaine 
responses, KO animals were used in several behavioral paradigms (Rocha et al., 2002). 
Baseline locomotor responses revealed increased activity in KO animals, though 
habituation did occur over a 4 day period. KO animals also displayed enhanced 
locomotor responses to cocaine with significantly increased amounts of DA release in 
the NAc following cocaine administration. Using self-administration studies, KO animals 
made significantly more lever presses, pressing the active lever twice as many times as 
WT animals to obtain significantly larger number of cocaine injections. These studies 
25 
 
implicate 5HT2C receptors in the psychostimulant and reinforcing effects of cocaine 
through activation of mesolimbic DA transmission (Rocha et al., 2002).  
In studies with the hypothalamic-pituitary-adrenal (HPA) axis, 5HT2C receptors 
have been determined to be necessary for 5HT-induced HPA axis activation (Heisler et 
al., 2007a). HPA axis activation is modulated by many inputs converging on the 
paraventricular nucleus of hypothalamus (PVH), where corticotrophin-releasing hormone 
(CRH) is synthesized (Spiess et al., 1981). Within the PVH, high levels of expression of 
5HT2C receptor were found and approximately one-half of these receptors overlapped 
with the distribution of CRH neurons. The high affinity 5HT2C receptor agonist, mCPP, is 
able to depolarize PVH neurons and the 5HT2C receptor antagonist, RS102221, can 
block this effect; 5HT2C receptor KO mice do not display increases of CRH release or 
CRH mRNA in response to mCPP, suggesting that 5HT enhances the activity of PVH 
CRH neurons via activation of 5HT2C receptors. Furthermore, 5HT2C receptor KO 
animals exhibit blunted CRH and corticosterone (CORT) release after 5HT-induced HPA 
axis stimulation, demonstrating the involvement of 5HT2C receptors in HPA axis function 
(Heisler et al., 2007b).  
5HT2C receptor KO animals also demonstrate decreased anxiety in several 
behavioral paradigms (elevated zero maze, open field, response to novel object, 
mirrored chamber) (Heisler et al., 2007b). To investigate the possible mechanisms 
through which anxiety-related behaviors are altered in KO animals, c-fos 
iummunoreactivity (FOS-IR), a marker of neuronal activation, was used following 
exposure to anxiety stimuli; KO animals were found to have selective reductions of FOS-
IR in the bed nucleus of stria terminalis (BNST) and the central nucleus of the amygdala 
(CeA). These brain regions are rich in CRH neurons (Swanson et al., 1983) and KO 
animals were also found to have a blunted response in extended amygdala CRH 
neuronal activation in response to anxious stimuli (Heisler et al., 2007b). Taken together, 
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these data suggest that 5HT2C receptor-mediated modulation of limbic CRH is important 
in the regulation of anxiety-related behaviors. 
To determine if expression of other serotonin family receptors or the serotonin 
transporter (SERT) are altered in response to genetic ablation of the 5HT2C receptor, 
Lopez-Gimenez et al. (Lopez-Gimenez et al., 2002) performed autoradiographic analysis 
for members within the 5HT family in 5HT2C receptor KO animals. As expected, 
differences between WT and KO animals were found using radioligands that label the 
5HT2C receptor. KO animals had an absence of labeling in the choroid plexus and 
decreased labeling in other brain regions. However, no significant alterations were found 
with the remaining radiolabeled ligands in any brain region, indicating that the mouse 
5HT system does not exhibit any obvious compensatory regulation of SERT or other 
5HT receptor subtypes in the absence of 5HT2C receptors. This is somewhat surprising, 
given that animals lacking SERT display alterations in 5HT1A receptor (Fabre et al., 
2000; Li et al., 2000), 5HT1B receptor (Fabre et al., 2000), 5HT2A receptor (Rioux et al., 
1999) and 5HT2C receptor (Li et al., 2003) mRNA levels and/or function, indicating that 
the ablation of other 5HT family members, or at least SERT, leads to adaptive 
compensatory alterations.  
 
 
Specific Aims 
 
 The monoamine neurotransmitter serotonin (5-hydroxytryptamine; 5HT) elicits a 
wide array of physiological effects by binding to distinct receptor subtypes encoded by at 
least fourteen separate genes. RNA transcripts encoding the 2C-subtype of the 
serotonin receptor (5HT2CR) are modified by a novel processing event, referred to as 
RNA editing, in which up to five specific adenosine residues can be converted to inosine, 
thereby altering the encoded amino acid residues at positions 157, 159 and 161 of the 
receptor to generate as many as twenty-four 5HT2C receptor protein isoforms. These 
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modified receptors are expressed in a region-specific manner in the central nervous 
system (CNS) and demonstrate differences in their efficacy to interact with specific G-
proteins. We hypothesize that RNA editing of the 5HT2C receptor serves to enhance 
genetic diversity by generating multiple protein isoforms from a single genomic locus and 
that these isoforms, each possessing distinct expression patterns and functional 
properties, serve unique physiological roles in the CNS. 
 
To address this hypothesis, the following specific aims were proposed: 
 
 
I. To evaluate the developmental regulation of 5HT2C receptor expression and RNA 
editing patterns. To characterize potential changes in RNA editing during development, 
male mice at various developmental stages (embryonic days (E) 15 and 19, postnatal 
days (P) 0, 21, adult) were collected and RNA was prepared from whole brain. RNA 
editing of the 5HT2C receptor, as well as other substrates that undergo A-to-I conversion 
was quantified. Expression levels for ADAR1, ADAR2 and 5HT2C receptor mRNA levels 
were quantified using real-time RT-PCR and the developmental patterns of expression 
were determined.  
 
II. To generate a mutant strain of mouse solely expressing the non-edited (INI) 
isoform of the 5HT2C receptor. To further examine the physiologic relevance of 
multiple, functionally-distinct 5HT2C receptor isoforms, mice capable of expressing only 
the non-edited (INI) isoform were generated via targeted gene modification in embryonic 
stem cells. Mutant mice were assessed for potential alterations in the level of 5HT2C 
receptor mRNA expression, alterations in the patterns of 5HT2C receptor splicing and 
changes in 5HT2C receptor protein levels. 
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III. To characterize phenotypic alterations in INI-mutant mice. Previous studies in 
heterologous cell systems have revealed differences in the efficacy of receptor:G-protein 
coupling between edited 5HT2C receptor isoforms, yet the physiological relevance of this 
differential coupling has yet to be examined in a whole animal model system. Since the 
INI isoform of the 5HT2C receptor exhibits the greatest basal activity and agonist potency 
resulting from enhanced G-protein coupling (Berg et al., 2001; Herrick-Davis et al., 
1999), it is hypothesized that mutant mice bearing the INI allele will show phenotypic 
alterations resulting from enhanced signaling capacities compared to wild-type animals.  
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CHAPTER II 
 
 
DEVELOPMENTAL REGULATION OF RNA EDITING 
 
 
Introduction 
 
RNA editing is a prevalent post-transcriptional processing event that can involve 
the substitution or deletion of RNA sequences or the modification of specific nucleoside 
bases. These sequence alterations serve to generate genomic diversity in the 
transcriptome by producing multiple protein isoforms from a single genomic locus (Gott 
and Emeson, 2000). In this process, adenosine residues undergo a site-selective 
hydrolytic deamination to inosine (A-to-I editing) in pre- and mature mRNA transcripts 
that is catalyzed by a family of double-stranded RNA-specific adenosine deaminases 
referred to as adenosine deaminases that act on RNA (ADARs) (Bass et al., 1997; Gott 
and Emeson, 2000). 
The mammalian ADAR family has two catalytically active family members, 
ADAR1 and ADAR2 (Bass, 2002). Each of these enzymes contains multiple copies of a 
double-stranded RNA-binding motif that are required for the binding of ADARs to their 
target transcript(s) and an adenosine deaminase domain near the carboxyl terminus that 
is required for catalytic activity (Figure 9) (Hough and Bass, 1994; Kim et al., 1994a; Kim 
et al., 1994b; Maas et al., 1996; O'Connell and Keller, 1994; O'Connell et al., 1995). 
ADAR1 and ADAR2 have been shown to edit all of the identified mammalian adenosine 
to inosine editing sites, including transcripts encoding multiple subunits of the AMPA 
(GLUR2, Q/R and R/G sites; GLUR3, R/G site; GLUR4, R/G site) and kainate (GLUR5, 
Q/R site; GLUR6, Q/R, I/V and Y/C sites) subtypes of ionotropic glutamate receptors, the 
2C-subtype of serotonin receptor (5HT2C, sites A-E), the α3 subunit of the GABAA 
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receptor (Gabra3, I/M site) and a voltage-gated potassium channel (Kv1.1, I/M site) 
(Bhalla et al., 2004; Rueter and Emeson, 1998; Rueter et al., 1999; Rula et al., 2008). 
 
 
 
Figure 9: ADAR functional domains. A schematic representation of the ADAR1, 
ADAR2 and ADAR3 proteins is shown. Their relative size in amino acids, as well as the 
location of the putative nuclear localization (NLS) and export (NES) signals, arginine-rich 
(R) domain, Z-DNA binding domains (Zα and Zβ), double-stranded RNA binding motifs 
(dsRBMs) and the adenosine deaminase domain are presented.  
 
 
RNA editing can alter the amino acid coding potential of the mRNA and thereby 
alter the function of the encoded protein product. Such changes include modulation of 
Ca2+ permeability (GLUR2, GLUR5, GLUR6) (Egebjerg and Heinemann, 1993; Kohler et 
al., 1993; Sailer et al., 1999; Sommer et al., 1991), alteration of recovery from receptor 
desensitization (GLUR2, GLUR3, GLUR4) (Lomeli et al., 1994), channel inactivation 
(Kv1.1) (Bhalla et al., 2004), and modulation of constitutive activity and G-protein 
coupling efficacy (5HT2C receptor) (Burns et al., 1997; Niswender et al., 1999; Niswender 
et al., 1998). In addition to alterations in coding potential, RNA editing can also affect the 
structure, stability, translation efficiency and splicing patterns of edited transcripts (Bass, 
2002; Gott and Emeson, 2000). Moreover, environmental factors, such as early life 
stress and antidepressant drug administration, have been shown to alter the editing 
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patterns of ADAR substrates (Bhansali et al., 2007; Gurevich et al., 2002a). Alterations 
in RNA editing patterns for the 5HT2C receptor have been observed in numerous human 
neuropsychiatric diseases, including schizophrenia, depression and suicide (Gurevich et 
al., 2002b; Niswender et al., 2001; Sodhi et al., 2001), whereas a decrease in editing at 
the Q/R site of GLUR2 mRNAs has been associated with the selective death of spinal 
motor neurons in sporadic amyotrophic lateral sclerosis (Kawahara et al., 2004; 
Kawahara et al., 2006). 
Both ADAR1 and ADAR2 are known to be highly expressed in the brain, yet 
limited studies have been performed to characterize region-specific patterns of 
expression during development. One such study used in situ hybridization analyses to 
determine the developmental pattern of ADAR2 expression in the rat (Paupard et al., 
2000). This study reported the earliest expression of ADAR2 in the ventral thalamus 
during late embryonic development, while at birth expression was still restricted to 
thalamic nuclei. ADAR2 expression was detected more broadly and near peak levels by 
postnatal day (P)21 and leveled off into adulthood with the greatest hybridization signal 
detected in hippocampus, olfactory bulb and thalamus. This restricted pattern of ADAR2 
expression during development was quite surprising given the broad expression pattern 
for GLUR2 transcripts in the central nervous system and previous observations 
regarding the high efficiency (>99%) by which the Q/R site is edited within whole brain-
derived GLUR2 mRNAs during development (Sommer et al., 1991). Recent findings by 
the GENSAT Consortium (http://www.gensat.org/index.html) and the Allen Brain Atlas 
(http://www.brainatlas.org/aba) have suggested a more widespread distribution of the 
ADAR enzymes.  
Developmental and regional mapping of ADAR1 in the brain have not been 
reported, and homozygous ADAR1-null animals die at E11.5-12.5 (Hartner et al., 2004; 
Wang et al., 2004); the phenotype is characterized by slowed development, an altered 
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fetal liver structure and impaired hematopoiesis, as well as widespread apoptosis in 
heart, liver and vertebra. Examination of the neuroepithelium did not display any 
abnormalities (Hartner et al., 2004) raising questions regarding what role(s) ADAR1 may 
play, if any, during neurological development.  
There is limited data describing not only developmental regulation of ADAR 
enzymes, but also of editing patterns for ADAR substrates, particularly the 5HT2C 
receptor. Characterization of 5HT2C receptor expression in developing mice is limited to 
a single survey demonstrating receptor immunoreactivity as early as E10-10.5 in the 
mesenchyme underlying the mesencephalic flexure of the brain (Lauder et al., 2000). 
Immunohistochemical as well as Northern and western blotting analyses performed 
during rat brain development have been more extensive, indicating that 5HT2C receptor 
mRNA levels increase 5-fold between E17 and P27 and reach peak levels by P13 (Roth 
et al., 1991); however, 5HT2C receptor protein levels demonstrate a more attenuated 
developmental profile, increasing only 2-fold during the same time period (Roth et al., 
1991). In sharp contrast to the 5HT2C receptor is the developmental expression of the 
5HT2A receptor, which shows a 54% amino acid homology to the 5HT2C receptor, with 
considerably sequence similarity in the putative transmembrane regions. 5HT2A receptor 
mRNA levels increase 13-fold between E17 and P27, peaking around P5, while protein 
levels increase by 8-fold between E17 and P13 and then decline (Roth et al., 1991). 
Monoclonal antibodies generated against 5HT2C receptor have been used to examine 
5HT2C receptor levels in different brain regions (cortex, hippocampus, brainstem, 
cerebellum, thalamus and others). Expression levels of the 5HT2C receptor in cerebral 
cortex, cerebellum and other tissues was expressed at a high level by P3 and increased 
only slightly during further postnatal development. In brainstem, 5HT2C receptors were 
also highly expressed by P3, they continued to increase slightly until P14 and then 
declined at P21; in the hippocampus, 5HT2C receptors were detected at low levels by P3 
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and their expression increased throughout subsequent development (Li et al., 2004). 
Transient expression of 5HT2C receptors in layer IV of rat primary sensory cortex and 
thalamus during P7 to P28 further supported a potential involvement of the 5HT2C 
receptor in neuronal plasticity. 
Thus, our current study examined the temporal and spatial regulation of ADAR1 
and ADAR2 in mouse forebrain, as well as developmental regulation of RNA editing in 
multiple ADAR substrates. Our data suggest that ADAR1 and ADAR2 are expressed 
broadly across nearly all brain regions by P0. Furthermore, these enzymes appear to be 
expressed in neurons, but not in glial cells, in the mouse forebrain, supporting a potential 
role for RNA editing in neuronal development across a wide variety of forebrain regions. 
 
 
Experimental procedures 
 
Animals 
129S6/SvEvTac (Taconic, Hudson, NY) male mice from the following 
developmental stages: E15, E19, P0, P21, P100 (plug day=E0, n=6) were used for this 
study. To determine the gender of embryonic and early postnatal day animals, a PCR-
based strategy was developed to detect the genes encoding Smcy and its X-
chromosome homolog Smcx. Both Y and X chromosome homologs are widely 
expressed in all male tissues and SMCX escapes X-inactivation in females (Agulnik et 
al., 1994). PCR amplification using primers (sense: 5'-CCGCTGCCAAATTCTTTGG-3', 
antisense: 5'-TGAAGCTTTTGGCTTTGAG-3') designed to amplify both X- and Y- copies 
generated amplicons of 290 and 330 bp, respectively (Jimenez et al., 2003).  
 
Immunohistochemistry 
At E15, dams were deeply anesthetized with sodium pentobarbital and embryos 
were obtained by Caesarean section. Whole embryonic heads were immersion-fixed in 
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4% paraformaldehyde. For postnatal ages, mice were deeply anesthetized with sodium 
pentobarbital and transcardially perfused with 4% paraformaldehyde. Brains were 
removed and postfixed overnight at 4°C. All brains were immersed in a series of sucrose 
(10%, 20%, 30%) solutions prior to sectioning for immunohistochemistry. Coronal 
sections were cut on a freezing microtome at 40 µm, or on a cryostat (20 µm, E15 only), 
and stained using modifications of previously published protocols (Stanwood et al., 
2005; Stanwood et al., 2001). Briefly, sections were treated with 0.1 M glycine (pH 7.4) 
to reduce nonspecific labeling, blocked in 4% nonfat dried milk, 0.2% Triton-X 100 in 
PBS (pH 7.4) and incubated at 4°C for 3 days with antibodies directed against ADAR1 
[guinea pig polyclonal; 1:1000, (George et al., 2005)] and ADAR2 [sheep polyclonal; 
1:500, (Rueter et al., 1999; Sansam et al., 2003)], respectively. Following five washes in 
blocking solution at room temperature, sections were incubated with biotinylated anti-
mouse, anti-rabbit, anti-sheep or anti-guinea pig IgG (Jackson, 1:1000) for 60 min. 
Avidin-biotin amplification (Vectastain ABC Standard, Vector Laboratories, Burlingame, 
CA) and 3-3'-diaminobenzidine reactions were used to visualize labeled proteins. 
Sections from different ages were processed in parallel to minimize variability across 
developmental time points. Adjacent sections were stained with 0.5% cresyl violet to aid 
in anatomical identification of regions of interest. Negative controls, in which primary 
antibodies were omitted, revealed no specific labeling. Background labeling of blood 
vessels was observed in the E15-derived samples.  
Immunofluorescent techniques were used for colocalization analyses where 
mouse monoclonal antibodies directed against either NeuN (Chemicon MAB377; 1:100), 
glial fibrillary acidic protein (Chemicon MAB360; 1:250), or S100β (DakoCytomation 
Z0311, 1:4000) were used in combination with guinea pig anti-ADAR1 and sheep anti-
ADAR2 antisera; appropriate Cy2- and Cy3-labeled secondary antibodies were utilized 
(1:1000, Jackson). Sections were mounted onto gelatin/poly-L-lysine-coated slides, 
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dehydrated, coverslipped with DPX (EMS, Hatfield PA) and imaged using an Axioplan II 
microscope and Axiocam HR (Carl Zeiss, Thornwood, NY). Images were digitally 
captured using Axiovision software (version 4.1) and exported as TIFF files. Images 
were merged in Adobe Photoshop where brightness was adjusted, as necessary. Fields 
within the cerebral cortex and hippocampus were collected for cell counting in a subset 
of the adult animals (n=3-4 animals per immunohistochemistry condition). 
 
RNA characterization 
At each developmental age, mice (n ≥ 6) were rapidly sacrificed and whole brain 
or brain regions (adult only: choroid plexus, cortex, hippocampus, hypothalamus, 
olfactory bulb, striatum) was immediately frozen in liquid nitrogen. RNA was isolated and 
purified using a PerfectPure RNA tissue kit (5 PRIME, Gaithersburg, MD) according to 
the manufacturer's instructions.  
 For isolation of specific brain region, dissections were performed as described in 
Glowinski and Iversen (Glowinski and Iversen, 1966). Briefly, a coronal cut was made on 
the ventral surface of the brain at the level of the optic chiasm (Bregma ~-0.3 mm). The 
region generated from this first cut was used to harvest cortex and striatum; olfactory 
bulb was removed and striatum was separated from cortex with corpus callosum and 
lateral ventricles defining the boundaries. The residual white matter was removed and 
remaining tissue was defined as cortex. Choroid plexus was removed from both lateral 
ventricles and the third ventricle. In the remaining tissue sample, the hippocampus was 
removed and then a second coronal cut was made in front of the cerebellum (Bregma 
~3.2 mm). Hypothalamus was separated from thalamus using the anterior commissure 
and mammillary bodies as reference boundaries. 
To determine the 5HT2C receptor editing pattern during development, a 
Pyrosequencing™ (Biotage AB, Uppsala, Sweden) strategy was utilized with individual 
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cDNA clones at each age, as described (Sodhi et al., 2005). Briefly, first strand cDNA 
was synthesized using avian myeloblastosis virus reverse transcriptase (AMV-RT, 
Promega, Madison, WI) and then amplified using specific primers (sense: 5'-ATT 
AGAATTCTATTTGTGCCCCGTCTGG-3', antisense: 5'-ATCAAAGCTTGACGGCGTAG 
GACGTAG-3') to amplify the region of the 5HT2C receptor containing the editing sites as 
well as flanking sequence. Following RT-PCR amplification, amplicons were purified and 
subcloned into a pGEM-Easy T vector (Promega, Madison, WI). Individual clones were 
selected (n≥50 for each animal, total≥300) and PCR amplification of a single bacterial 
colony was performed using a biotinylated antisense primer (5'-
CGAATTGAAACGGCTATGCT-3'). PCR products were then incubated with streptavidin 
sepharose beads (GE Healthcare, Piscataway, NJ) and this mixture was transferred to a 
Multiscreen PCR filter plate (Millipore, Billerica, MA). The double-stranded PCR product 
was denatured and the biotinylated antisense strand remained bound to the filter. The 
antisense strand was annealed to a sequencing primer (5'-
ATATCGCTGGATCGGTATGTAG-3') that terminated before the editing sites. This assay 
was developed for a 96-well plate format and the plate and a cartridge containing 
substrates [adenosine 5' phosphosulfate (APS) and luciferin], enzymes (DNA 
polymerase, ATP sulfurylase, luciferase and apyrase) and dNTPs was loaded into the 
Pyrosequencer. Computer software automatically dispensed each of the cartridge 
components, beginning with substrates and enzymes. At each cycle, a dNTP was added 
to the reaction; DNA polymerase catalyzed addition of the base if it was complementary 
and each incorporation resulted in the release of inorganic pyrophosphate (PPi). ATP 
sulfurylase converted PPi to ATP using APS as an adenosine donor; ATP then catalyzed 
the luciferase-mediated conversion of luciferin to oxyluciferin to generate light. This 
visible light was detected by a charge couple device (CCD) camera and the software 
represented this light as a peak on a pyrogram™. 
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To determine the extent of site-selective editing for other ADAR substrates, first 
strand cDNA was synthesized from 1µg of total RNA using 10U AMV RT (Promega, 
Madison, WI) in a 10µl reaction containing 5µM random hexamers (Applied Biosystems, 
Foster City, CA), 1mM dNTPs (New England Biolabs, Ipswich, MA) and 10U RNasin 
(Promega, Madison, WI), under the following conditions: 25°C for 10 minutes, 42°C for 
1hr and 95°C for 5 minutes followed by PCR amplification using Ampli-Taq DNA 
polymerase (Applied Biosystems, Foster City, CA), and assessed by a modified primer-
extension analysis (Rueter et al., 1999). The extension products were resolved by 
denaturing polyacrylamide gel electrophoresis and quantified using phosphorimager 
analyses (GE Healthcare, Piscataway, NJ) as previously described (Feng et al., 2006). 
To quantify levels of mRNA expression, first-strand cDNA was synthesized as 
described above and subjected to TaqMan real-time PCR analysis (Applied Biosystems, 
Foster City, CA). All primers and probes used for real-time PCR analysis were products 
of Assay-On-Demand from Applied Biosystems (ADAR1, assay ID Mm00508001_m1; 
ADAR2, assay ID Mm00504621_m1; 5HT2CR, assay ID Mm00434127_m1). Eukaryotic 
18S rRNA (product no. 4319413E; Applied Biosystems, Foster City, CA) was included in 
each multiplex PCR as an internal control. Real-time PCR and subsequent analysis were 
performed with an ABI Prism 7900HT sequence detection system (SDS v2.3; Applied 
Biosystems, Foster City, CA). Quantitation of target gene expression in all samples was 
normalized to 18S rRNA expression by the equation CT(target) – CT(18S) =∆CT, where CT is 
the threshold cycle number. The mean ∆CT value of samples from each tissue for all 
wild-type animals was determined and used as a reference point for the samples from 
the same tissues for mice. Differences between wild-type mice and each developmental 
time point, including individual variation, were calculated by the equation ∆CT(individual age) – 
∆CT(mean wild-type) = ∆∆CT. Changes in target gene expression (n-fold) in each sample were 
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calculated by 2-(∆∆CT) from which the means and standard errors of the mean (SEM) were 
derived. 
 
Statistical Analyses 
All statistical analyses were performed using GraphPadPRISM (GraphPad 
Software, Inc., La Jolla, CA), unless otherwise indicated. Values are reported as mean ± 
SEM, and P values of <0.05 were considered significant. 
 
 
Results 
 
ADAR1 and ADAR2 Transcripts 
ADAR1 and ADAR2 mRNA levels were determined over a developmental time 
course in whole mouse brain using quantitative real-time RT-PCR (qPCR). Overall, the 
steady-state level of ADAR1 and ADAR2 transcripts increased gradually during 
development. At E15, expression of each of these mRNAs was relatively low, and 
expression continued to increase for each ADAR-encoding mRNA species through 
adulthood (P100; Figure 10).  
 To further assess the expression of ADAR1 and ADAR2 transcripts in dissected 
brain regions from adult mice, we again used qPCR to quantify steady-state mRNA 
levels in frontal cortex, hippocampus, hypothalamus, olfactory bulb, striatum, thalamus 
and choroid plexus; values from dissected brain regions were normalized to whole brain 
expression levels (Figure 11). ADAR1 displayed relatively low levels of expression in the 
choroid plexus, frontal cortex and hippocampus (p<0.001 for each region as compared 
to whole brain; Figure 11A). In contrast, ADAR1 appeared to be relatively enriched in the 
hypothalamus and thalamus (Figure 11A), while ADAR1 levels in the olfactory bulb and 
striatum were comparable to those from whole brain.  
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Figure 10: Temporal regulation of ADAR1 and ADAR2 expression. ADAR1 and 
ADAR2 mRNA expression in whole mouse brain over a developmental time course was 
determined (mean ± SEM) by qPCR. Expression levels of each ADAR were normalized 
to the adult mRNA level and varied significantly in developing mouse brain by one-way 
ANOVA (p<0.001). Dunnett’s post-hoc tests revealed that each age differed significantly 
from adult ADAR levels (p<0.01). 
 
 
 
 
 
Figure 11: Region-specific expression of ADARs in the adult mouse brain. The 
relative expression of ADAR1 (a) and ADAR2 (b) mRNA was quantified by qPCR in 
mouse whole brain, and in dissected brain regions. For each region, values are 
expressed as mean ± SEM and normalized to the expression value observed in whole 
brain samples. a) Choroid plexus, cortex and hippocampus ADAR1 mRNA levels are 
significantly different that whole brain mRNA (individual t-test, Bonferroni post-hoc 
analyses). b) Cortical, hippocampal and thalamic ADAR2 transcripts are significantly 
different than whole brain transcripts (individual t-test, Bonferroni post-hoc analyses), *: 
p<0.001. 
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The general enrichment pattern for ADAR2 in most brain regions was similar to 
that for ADAR1, with the lowest relative expression levels observed in frontal cortex and 
hippocampus (Figure 11B). ADAR2 mRNA expression was the highest in the thalamus, 
with a two-fold increase relative to whole brain (Figure 11B). ADAR2 expression in the 
choroid plexus, hypothalamus, olfactory bulb and striatum was comparable to that of 
whole brain. 
ADAR1 and ADAR2 Protein 
 To examine the spatial pattern of ADAR1 and ADAR2 protein expression, we 
used an immunohistochemical strategy with previously characterized ADAR-specific 
antisera (George et al., 2005; Rueter et al., 1999; Sansam et al., 2003). In adult mice, 
expression of both ADAR1 and ADAR2 protein was detected throughout the forebrain 
(Figures 12 and 13). ADAR1 labeling was prominent in the nuclei of cells contained 
within nearly all grey matter brain regions, including the cerebral cortex (Figure 12B and 
12C), striatum (Figure 12C), hippocampus (Figure 12D), thalamus (Figure 12E), 
hypothalamus (Figure 12F) and amygdala (Figure 12G). 
Even more intense labeling was observed using antisera derived against ADAR2 
(Figure 13) in nearly all forebrain regions examined. Qualitatively, both ADAR1- and 
ADAR2-immunoreactivity appeared to be restricted to neurons, but expressed 
ubiquitously across neuronal subtypes. Colocalization studies using markers of neurons 
(NeuN) and astrocytes (GFAP, S100β) confirmed these findings [Figures 14 (low power) 
& 15 (high power)]. 
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Figure 12: ADAR1 protein expression in the adult mouse forebrain. Sagittal (a) and 
coronal (b-g) sections of adult (P100) mouse brain were stained with specific anti-
ADAR1 antisera; note the widespread expression in cell nuclei in most brain regions. 
Scale bars = 500 µm (a) and 200 µm (b-g). Abbreviations: PrL CTX = prelimbic cortex; 
cc = corpus callosum; STR = striatum; CA1 = CA1 subregion of hippocampus; CA3 = 
CA3 subregion of hippocampus; HYPO = hypothalamus. The sagittal section was 
reconstructed as overlays from images captured at higher power in Adobe Photoshop, 
thus resulting in different apparent levels of background on different areas of the section. 
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Figure 13: ADAR2 protein expression in the adult mouse forebrain. Sagittal (a) and 
coronal (b-g) sections of adult (P100) mouse brain were stained with specific anti-
ADAR2 antisera; note the widespread expression in cell nuclei in most brain regions. 
Scale bars = 500 µm (a) and 200 µm (b-g). Abbreviations: PrL CTX = prelimbic cortex; 
cc = corpus callosum; STR = striatum; CP = choroid plexus; CA1 = CA1 subregion of 
hippocampus; DG = dentate gyrus of hippocampus; zi = zona incerta; ml = medial 
lemniscus; md = mediodorsal thalamic nucleus; vp = ventroposterior thalamic nucleus; 
dm Hypo = dorsomedial hypothalamus; vm Hypo = ventromedial hypothalamus; post 
Hypo = posterior hypothalamic nucleus; Amyg = amygdala. The sagittal section was 
reconstructed as overlays from images captured at higher power in Adobe Photoshop, 
thus resulting in different apparent levels of background on different areas of the section. 
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Figure 14: ADAR1 and ADAR2 protein colocalizes with NeuN, but not GFAP in the 
adult mouse forebrain. Coronal sections of adult (P100) mouse brain were stained with 
specific antibodies against NeuN (a, g), GFAP (d, j), ADAR1 (b, e), and ADAR2 (h, k). 
Overlayed images (c, f, i, l) demonstrate colocalization of ADAR1 and ADAR2 with 
NeuN, but not GFAP. Scale bar = 200 µm. Abbreviations: CTX = cortex; cc = corpus 
callosum; STR = striatum. 
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Figure 15: ADAR1 and ADAR2 protein is expressed in neurons but not glial cells. 
Coronal sections of adult (P100) mouse brain were double labeled with specific 
antibodies against GFAP (green - a, b), S100β (green - c, d) or NeuN (green - e, f), as 
well as ADAR1 (red - a, c, e) or ADAR2 (red - b, d, f). High power photomicrographs 
demonstrate prominent colocalization of ADAR1 and ADAR2 with NeuN, but not GFAP 
or S100β. Scale bar = 25 µm.  
 
 
We also quantified the extent of colocalization in two brain regions, the cerebral 
cortex and hippocampus. The vast majority of ADAR1- and ADAR2-immunoreactive 
cells were positive for NeuN (97.6% ± 1.58% and 99.0% ± 0.333%, respectively). In 
contrast, very few ADAR1- and ADAR2-immunoreactive cells were positive for GFAP 
(0.513% ± 0.230% and 0.550% ± 0.268%, respectively) or S100β (1.32% ± 0.178% and 
3.02% ± 1.41%, respectively). Similar results were obtained in the hippocampus, with 
NeuN detected in the majority of ADAR1- and ADAR2-immunoreactive cells (96.9% 
±0.515% and 92.6% ± 2.03%, respectively), but very little co-expression of ADAR1 or 
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ADAR2 with GFAP (0% ± 0% and 1.67% ± 1.67%, respectively) or S100β (3.67% ± 
1.41% and 6.00% ± 1.79%, respectively). 
We then assessed ADAR1 and ADAR2 protein expression developmentally, 
examining labeling patterns at E15, P0 and P21. At E15, the earliest stage examined, no 
specific immunoreactivity for ADAR2 was detected within the forebrain (Figure 16 B, D, 
F). ADAR1-immunoreactive cells were seen only occasionally, with no clear delineation 
of cell type (Figure 16A, C, E).  
 
 
Figure 16: Paucity of ADAR1 or ADAR2 protein expression in E15 mouse 
forebrain. Coronal sections of E15 mouse brain were stained with specific anti-ADAR1 
(a, c, e) and anti-ADAR2 (b, d, f) antisera, but no specific cellular labeling was observed. 
Arrowheads indicate labeling of blood vessels rather than specific cellular labeling. Scale 
bar = 200 µm. Abbreviations: lv = lateral ventricle; ge = ganglion eminence; cp = cortical 
plate; iz = intermediate zone of cortex; ha = habenula; 3rd v = third ventricle; hypo = 
hypothalamus. 
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By P0, robust expression of both ADAR1 and ADAR2 protein was detected 
(Figures 17 and 18). For example, ADAR1 was observed within superficial and deep 
layers of the still developing cerebral cortex (Figure 17A), hippocampus (Figure 17C), 
thalamus (Figure 17D) and hypothalamus (Figure 17D). Labeling in the striatum was 
limited, however (Figure 17B). Nearly identical patterns of ADAR2 protein expression 
were observed at P0 (Figure 18). Co-localization studies again revealed expression of 
each editing enzyme with NeuN, but not GFAP (Figure 19). Expression patterns nearly 
indistinguishable from the adult were observed at P21 (Figures 20 and 21), consistent 
with qPCR analyses of ADAR1 and ADAR2 transcripts (Figure 10). 
 
 
 
 
Figure 17: ADAR1 protein expression in mouse brain at P0. Coronal sections of P0 
mouse brain were stained for ADAR1; note the widespread expression in deep and 
superficial layers of the still developing cerebral cortex (a, b), hippocampus (c), thalamus 
(d), and hypothalamus (d). Labeling in the striatum is fairly low (b). Scale bar = 200 µm. 
Abbreviations: CTX = cortex; cc = corpus callosum; STR = striatum; CA1 = CA1 
subregion of hippocampus; DG = dentate gyrus of hippocampus; thal = thalamus; hypo 
= hypothalamus. 
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Figure 18: ADAR2 protein expression in mouse brain at P0. Coronal sections of P0 
mouse brain were stained for ADAR2. Similar to ADAR1, widespread expression in deep 
and superficial layers of the still developing cerebral cortex (a, b), hippocampus (c), 
thalamus (d), and hypothalamus (d) is readily observed. Labeling in the striatum is fairly 
low (b). Scale bar = 200 µm. Abbreviations: CTX = cortex; cc = corpus callosum; STR = 
striatum; CA1 = CA1 subregion of hippocampus; DG = dentate gyrus of hippocampus; 
hypo = hypothalamus. 
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Figure 19: ADAR1 and ADAR2 protein colocalize with NeuN, but not GFAP in P0 
forebrain. Coronal sections of P0 mouse brain were stained with specific antibodies 
against NeuN (a, g), GFAP (d, j), ADAR1 (b, e), and ADAR2 (h, k). As in the adult, 
overlayed images (c, f, i, l) of P0 tissue demonstrate prominent colocalization of ADAR1 
and ADAR2 with NeuN, but not GFAP. Scale bar = 200 µm. Abbreviations: CTX = 
cortex; cc = corpus callosum; lv = lateral ventricle; STR = striatum. 
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Figure 20: ADAR1 protein expression in mouse brain at P21. Coronal sections of 
P21 mouse brain were stained for ADAR1, revealing widespread expression similar to 
that observed in the adult. Abbreviations: CTX = cortex; cc = corpus callosum; STR = 
striatum; CP = choroid plexus; CA1 = CA1 subregion of hippocampus; DG = dentate 
gyrus of hippocampus; thal = thalamus; hypo = hypothalamus; Scale bar = 200 µm.  
 
 
 
Figure 21: ADAR2 protein expression in mouse brain at P21. Coronal sections of 
P21 mouse brain were stained for ADAR2, revealing widespread expression similar to 
that observed in the adult. Abbreviations: CTX = cortex; cc = corpus callosum; STR = 
striatum; CP = choroid plexus; CA1 = CA1 subregion of hippocampus; DG = dentate 
gyrus of hippocampus; thal = thalamus; hypo = hypothalamus; Scale bar = 200 µm.  
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ADAR1 and ADAR2 Substrate RNAs 
We next determined the editing patterns for several known ADAR1 and ADAR2 
substrates in RNA isolated from whole brain extracts at specific developmental time 
points (Figure 22). The 5HT2C receptor contains five editing sites (termed sites A-E) that 
can alter amino acids 157, 159 and 161, within the putative second intracellular loop of 
the receptor (Burns et al., 1997; Niswender et al., 1998). These edited isoforms have 
distinct functional properties affecting constitutive activity and the efficacy and specificity 
of receptor coupling to G proteins (Burns et al., 1997; Fitzgerald et al., 1999; Niswender 
et al., 1999). When we examined the extent of RNA editing at each of the five individual 
sites within mouse 5HT2C receptor transcripts, most appeared to follow similar 
developmental patterns of editing. With the exception of the D site, the other edited sites 
display low levels (~10-15%) of editing at E15 and reach adult levels of editing by P0 
(Figure 22A). The D site, however, was already edited in 50% of the transcripts at E15 
and increased at P21, when it reached adult levels (~75%). Editing at the D site changes 
a genomically-encoded isoleucine codon (AUU) to a valine codon (IUU), yet this amino 
acid alteration has little effect on the signaling properties of the 5HT2C receptor 
(Niswender et al., 1999). 
The Q/R site within GLUR2 transcripts is edited to near completion by E15 and 
maintains this level of editing throughout adulthood (Figure 22B), as previously 
described (Burnashev et al., 1992). Other substrates, including the GLUR2 R/G site, the 
GLUR5 Q/R site and the ADAR2 auto-editing site (-1 site) demonstrated modest editing 
at E15, with increases at P0 and P21, at which point the adult pattern of editing was 
achieved (Figure 22B). Interestingly, significant editing of the Kv1.1 I/V site appears to 
occur sometime after P0, substantially later than the other transcripts studied (Figure 
22B). 
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Figure 22: Developmental alterations in editing efficiency for multiple ADAR 
substrates. a) The extent of RNA editing for the five 5HT2C receptor editing sites (A-E) 
was determined by Pyrosequencing analysis from mouse whole brain transcripts 
isolated over a developmental time course. With exception of the D site, each site 
displayed low levels of editing at E15 that gradually and significantly increased to 
maximal levels by P0 (p<0.01), with very little increase observed between P0 and 
adulthood. b) The extent of RNA editing for several other ADAR substrates was 
determined by primer-extension analysis in mouse whole brain transcripts isolated over 
a developmental time course. With exception of the GluR-2 Q/R site, which was 
maximally edited at the earliest age examined, each substrate displayed low levels of 
editing at E15 that gradually and significantly increased to maximal levels in adult 
animals (p<0.01). 
 
 
Analysis of the 5HT2C receptor distribution in mRNA isolated from whole brain or 
dissected brain regions (choroid plexus, cortex, hippocampus, hypothalamus, olfactory 
bulb, striatum) in adult animals revealed that the pattern of RNA editing in the mouse 
was similar to that previously observed in the rat, where the VNV isoform of the receptor 
represented the major 5HT2C species in whole brain and most brain regions examined 
(Table 1). The choroid plexus remained a clear exception to this pattern however, with 
the major 5HT2C transcripts expressed in this tissue encoding the less edited INV and 
non-edited INI receptor isoforms. 
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Table 1: Quantitative analysis of region-specific 5HT2C receptor isoform 
expression in adult mouse brain. RNAs from whole mouse brain (WB), choroid plexus 
(CP), cortex (Cx), hippocampus (Hi), hypothalamus (Hy), olfactory bulb (OB) and 
striatum (Str) was amplified by RT-PCR, subcloned into a prokaryotic vector (pGEM-T) 
and individual cDNA isolates (>100 from each brain region) were analyzed by 
Pyrosequencing™. 5HT2C RNA isoforms, and the corresponding amino acid variants 
predicted by them, are indicated; numbers represent the percentage of cDNA isolates 
encoding each amino acid isoform and are color-coded according to the scale at the 
right. 
 
 
Discussion 
 
Using multiple experimental strategies, we have examined the spatiotemporal 
expression patterns for ADAR1 and ADAR2 in the mouse forebrain. Quantitative RT-
PCR analyses of ADAR1 and ADAR2 mRNA detected very low expression at E15, but 
robust and widespread expression by P0. ADAR1 and ADAR2 mRNA expression each 
appeared to increase steadily throughout development, with peak expression observed 
in adulthood. In adult animals, we examined ADAR1 and ADAR2 levels in whole brain, 
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as well as specific brain regions, to determine whether these editing enzymes 
demonstrated a preferential pattern of expression. ADAR1 and ADAR2 mRNA appear to 
be expressed at somewhat lower levels in the cortex and hippocampus, with message 
levels ~50% lower than that observed in whole brain. ADAR1 transcripts are most highly 
expressed in the hypothalamus and thalamus. ADAR2 also has higher expression in the 
thalamus than in other brain regions. High levels of RNA editing for several ADAR2-
specific substrates have been observed in the thalamus including the Q/R site of the 
GLUR5 subunit in rat (90%) (Paschen et al., 1994), the D site of the 5HT2C receptor in 
human (85%) (Wang et al., 2000b) and the I/M site of the α3 subunit of the GABAA 
receptor (90%) (Rula et al., 2008), suggesting that increased expression of ADAR2 in 
the thalamus can lead to maximal levels of RNA editing. 
A previous study of ADAR2 expression using in situ hybridization with 
oligonucleotide probes (Paupard et al., 2000) concluded that the ADAR2 transcript is not 
present at birth and appears gradually over the first week of life in a region-dependent 
manner. In contrast, our present study using quantitative RT-PCR revealed that ADAR2 
is widely distributed in mouse brain at birth and is expressed in all brain regions 
examined where editing substrates are expressed. Our data agree with the previous 
study (Paupard et al., 2000) in that expression was highest in the thalamus, suggesting 
that differences in assay sensitivity may have contributed to the observed differences 
between these studies. Like ADAR2, ADAR1 also shows widespread expression in the 
mouse brain and also suggests an extensive overlap between expression of editing 
substrates and the ADAR proteins. The Allen Brain Atlas and GENSAT databases 
present images of ADAR expression that are largely in agreement with our study, 
demonstrating that ADARs are widely distributed throughout the mouse forebrain by 
birth, with the possible exception of the striatum. The functional relevance of abundant 
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expression of both enzymes during development is unknown, but may relate to intrinsic 
differences in their substrate specificity. 
Further, we used double-label immunohistochemistry to determine the patterns of 
expression for ADAR1 and ADAR2 in neuronal and glial cells. Co-labeling studies 
performed with GFAP or NeuN indicated coexpression of ADAR1 and ADAR2 with 
NeuN. Only very limited ADAR1 or ADAR2 labeling was observed in GFAP- or S100β-
positive cells, indicating that ADARs are not expressed in most glial cells in the mouse 
forebrain. Although we did not use a direct marker of oligodendrocytes, we did not 
observe ADAR1 or ADAR2 labeling in any white matter tracts (Figures. 12, 13, 17, 18, 
20, 21), suggesting that these ADAR proteins may be largely restricted to neurons in the 
mouse forebrain. In contrast, low levels of ADAR transcripts and edited glutamate 
receptor subunits have been previously reported in white matter from humans 
(Kawahara et al., 2003). Thus, there may be pertinent species differences. 
Similar to previous reports (Burnashev et al., 1992; Paschen et al., 1997), we 
observed extensive editing of glutamate receptor transcripts prenatally. Data generated 
from knockout animals, single cell RT-PCR studies and in vitro editing activity assays 
have shown that the Q/R site is preferentially edited by ADAR2 (Higuchi et al., 2000; 
Melcher et al., 1996b). Our study reveals Q/R site editing to be greater than 99% by E15 
when ADAR2 mRNA is quite low and ADAR2 protein is barely detectable. Additionally, 
we find that the D-site of the 5HT2C receptor, a site that is preferentially edited by ADAR2 
(Burns et al., 1997; Niswender et al., 1998), is edited in 50% of the transcripts by E15, 
highlighting another discordant relationship between ADAR2 expression and RNA 
editing levels. It is possible that the Q/R site of GLUR2 and D-site of the 5HT2C receptor 
are kinetically favored and do not require abundant ADAR2 protein for efficient 
deamination, yet previous in vitro competition analyses revealed that the 5HT2C receptor 
duplex is particularly weak in its ability to compete for ADAR2-mediated editing (Dawson 
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et al., 2004). Alternatively, ADAR2 expression could be selectively increased in neurons 
expressing GLUR2 and 5HT2C receptor mRNAs; yet given the broad expression of 
AMPA receptors across neuronal subpopulations in the central nervous system (Geiger 
et al., 1995), it is unclear whether spatial patterns of A-to-I conversion in the brain reflect 
region-specific differences in ADAR expression. By contrast, the major 5HT2C receptor 
mRNA isoforms in the choroid plexus are either non-edited or edited solely at the D-site 
to encode isoleucine, asparagine and isoleucine (INI) or isoleucine, asparagine and 
valine (INV) in the second intracellular loop of the receptor, respectively (Table 1), a 
pattern consistent with low levels of ADAR1 and increased levels of ADAR2 in the adult 
rat and mouse brains (Burns et al., 1997)). While no catalytic activity for ADAR3 has 
been observed with known ADAR substrates or synthetic dsRNAs (Chen et al., 2000; 
Melcher et al., 1996a), it is possible that this protein may also be involved in the region-
specific regulation of editing patterns given its robust and restricted expression in the 
brain (Chen et al., 2000). Previous studies have suggested that ADAR3 may interfere 
with the activities of ADAR1 and ADAR2 by acting as a competitive inhibitor, thus 
decreasing the editing of specific substrates in those regions where it is preferentially 
expressed (e.g. thalamus) (Chen et al., 2000). 
We have demonstrated that ADARs are expressed at low levels in fetal brain, 
and increase gradually over time. ADAR1 mRNA has its lowest expression in choroid 
plexus, cortex and hippocampus, while ADAR2 mRNA is least expressed in cortex and 
hippocampus, with increased expression in the thalamus. We have also reported 
complete ADAR colocalization with NeuN, indicating that ADAR expression is restricted 
to neuronal populations. ADAR1 and ADAR2 expression do not necessarily correlate 
with the extent of editing activity for identified substrates, raising questions regarding the 
regulatory mechanisms that may be necessary to maintain normal spatiotemporal 
patterns of editing in the mammalian brain. While in vitro studies of A-to-I editing have 
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not demonstrated a requirement for any proteins other than ADARs for the site-selective 
editing of specific RNA substrates, the discordance between ADAR expression levels 
and editing patterns in mouse brain regions suggests that additional regulatory factors 
may be involved in the formation of protein-RNA complexes to modulate site-selective A-
to-I conversion. 
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CHAPTER III 
 
 
GENERATION OF 5HT2CRINI MICE 
 
 
Introduction 
 
The serotonin 2C receptor (5HT2CR) has been implicated in a variety of human 
neuropsychiatric and behavioral disorders, including depression, dysthymia, obsessive-
compulsive disorder, anxiety, schizophrenia and sleep disturbances (Dubovsky and 
Thomas, 1995; Frank et al., 2002; Julius, 1991; Masellis et al., 1998; Pandey et al., 
1995; Teitler and Herrick-Davis, 1994). 5HT2C receptor expression is limited to the 
central nervous system (CNS), with the highest levels of expression localized in choroid 
plexus and significant expression also found in hippocampus, striatum, amygdala and 
hypothalamus (Pasqualetti et al., 1999; Teitler and Herrick-Davis, 1994). Mutant mice 
lacking 5HT2C receptor expression display a variety of physiologic and behavioral deficits 
including leptin-independent hyperphagia and type 2 diabetes, death from spontaneous 
and audiogenic seizures, an increased sensitivity to the psychostimulant and reinforcing 
properties of cocaine and learning deficits resulting from hippocampal dysfunction 
(Brennan et al., 1997; Frank et al., 2002; Heisler et al., 1998; Nonogaki et al., 1998; 
Rocha et al., 2002; Tecott et al., 1998; Tecott et al., 1995). 
Sequence comparisons of rat, mouse and human 5HT2C receptor genomic DNA 
with their corresponding cDNAs revealed as many as five adenosine-to-guanosine (A-to-
G) discrepancies (Burns et al., 1997; Niswender et al., 1998; Wang et al., 2000b) 
indicative of adenosine-to-inosine (A-to-I) editing events in which specific adenosine 
moieties are post-transcriptionally converted to inosine by hydrolytic deamination 
(Polson et al., 1991). These five editing sites (termed sites A-E) are predicted to alter the 
genomically encoded amino acids (isoleucine, asparagine and isoleucine; INI) at 
58 
 
positions 157, 159 and 161 in the second intracellular loop of the receptor (Burns et al., 
1997; Wang et al., 2000b). Editing of 5HT2C receptor transcripts can generate as many 
as thirty-two different mRNA transcripts encoding up to twenty-four receptor isoforms 
that not only have distinct functional properties affecting constitutive activity and 
receptor:G-protein coupling in heterologous expression systems, but also differ in their 
pattern of CNS expression (Burns et al., 1997; Fitzgerald et al., 1999; Niswender et al., 
1999).  
The second intracellular loop of G-protein coupled receptors plays an important 
role in the coupling of G-proteins, especially for receptors linked to Gαq (Pin et al., 1994; 
Wong et al., 1990). Analysis of 5HT dose-response curves in transfected NIH-3T3 cells 
demonstrated that serotonergic agonists were 15- and 40-fold less potent when acting 
through the edited VSV and VGV receptor isoforms, respectively, suggesting that edited 
isoforms couple less efficiently to the intracellular signaling machinery (Burns et al., 
1997; Niswender et al., 1998). Studies with 5HT2C receptor have indicated that this 
receptor displays constitutive activity (Niswender et al., 1999) and competition binding 
studies using human isoforms of the 5HT2C receptor reveal that the INI isoform displays 
the greatest levels of constitutive activity. More recent studies have identified altered 
editing in patients diagnosed with schizophrenia (Sodhi et al., 2001), in suicide victims 
with a history of major depression (Gurevich et al., 2002b; Niswender et al., 2001) and in 
response to antidepressant treatment (Gurevich et al., 2002a), suggesting that editing 
may be involved in affective disorders and the maintenance of appropriate serotonergic 
neurotransmission. 
Given that RNA editing generates 5HT2C receptor isoforms that differ in G-protein 
coupling efficiency (Niswender et al., 1999), affecting both basal activity and ligand 
potency (Herrick-Davis et al., 1999), we sought to determine the physiologic relevance of 
5HT2C receptor editing in vivo by generating a mutant strain of mouse that solely 
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expresses the non-edited (INI) isoform of this receptor (5HT2CRINI). This chapter will 
focus on the biochemical alterations of 5HT2CRINI mutant mice, including alterations in 
5HT2C receptor mRNA and protein expression as well as changes in alternative splice 
patterns and DA levels in cortex and striatum. These changes highlight the importance 
and requirement for 5HT2C receptor RNA editing for normal brain function. 
 
 
Experimental Procedures 
 
Generation of DNA constructs 
Targeting vector 
A genomic fragment containing a segment of the mouse 5HT2C receptor was 
isolated from a 129X1/SvJ bacterial artificial chromosome (BAC) library (Genome 
Systems, Inc., St. Louis, MO) and a 7.4 kilobase (kb) Avr II fragment containing exon 5 
and a portion of the flanking introns was subcloned into modified pBluescript KSII- 
(pBKSII-, Strategene, La Jolla, CA) and was further characterized by detailed restriction 
and Southern blotting analysis, intron/exon boundary mapping and limited nucleotide 
sequence determinations (Figure 23). 
 A 360 base pair (bp) Acc I flanked restriction fragment was isolated from the 
original 7.4 kb fragment and subcloned into a pBKSII- vector in which the Acc I site had 
been eliminated (Acc-/pBKSII-); this Acc I fragment, containing the editing sites in exon 5 
and sequences from the 5'-end of intron 5, was used as a template for oligonucleotide-
directed site mutagenesis to introduce eleven point mutations into the editing-site 
complementary sequence (ECS), a region within intron 5 that is required for A-to-I 
editing of 5HT2C receptor transcripts. Mutations within this region disrupt the RNA duplex 
required for editing to take place while maintaining the coding potential of the gene. 
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Verification of INI mutations 
To confirm that the introduced mutations resulted in the loss of 5HT2C receptor 
editing prior to the generation of genetically-modified mice, minigene constructs 
containing the entire duplex region were generated via PCR (sense: 5'-
TATTTGTGCCCCGTCTGG-3' and antisense: 5'-ATATAAGCTTGACAACCGATCAAAC 
GCATGTTACCAGTCGACGTCTGTAGGTTGTT-3') from mouse genomic or INI-mutant 
DNA to create wild-type and INI minigenes, respectively. These PCR amplicons were 
subcloned into the eukaryotic expression vector pRC/CMV (Invitrogen, Carlsbad, CA). 
Each minigene (5µg) was then transiently co-transfected with ADAR1 or ADAR2 (20µg), 
into human embryonic kidney (HEK293) cells using Ca-PO4 coprecipitation. Crude 
nuclear extracts were prepared from transfected cells and immunoblotted using an anti-
ADAR1 (1:1000) or anti-ADAR2 antibody (1:1000) with histone deacetylase 2 (HDAC2, 
1:500) (Zeng et al., 1998) serving as an internal control for protein loading. 
RNA was harvested from transfected cells using Tri-Reagent (Molecular 
Research Center, Cincinnati, OH) according to the manufacturer’s instructions and 
cDNA was synthesized using an intron 5 specific primer containing a unique 5'-extension 
(5'-CGGC CAATCGTACGTACCTCCGACAACCGATCAAACGCATGTTACCAGTCGAC-
3'). Following cDNA synthesis, PCR was performed using a primer complementary to the 
unique extension (5'-CGGCCAATCGTACGTACCTCC-3') and a sense primer (5'-
TTTTGAATTCTATTTGTGCCCCGTCTGGATTTCAC-3') to amplify 5HT2C receptor 
transcripts. cDNA isolates were subcloned into pGEM (Promega, Madison, WI) and 
>100 cDNA clones were subjected to DNA sequence analysis to confirm that 
introduction of the mutations completely abolished editing while wild-type transfectants 
were efficiently edited by ADAR1 or ADAR2. 
Once verified, the 7.4 kb Avr II fragment and the 360 bp fragment containing the 
INI-mutation were digested with Acc I. Digested products were purified and ligated 
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together to generate an Avr II fragment containing the INI-mutations. A selection 
cassette encoding the phosphoglycerate kinase (PGK) promoter-driven herpes simplex 
virus thymidine kinase (TK) was inserted outside the region of homology as a negative 
selectable marker. To insert the loxP-flanked neomycin phosphotransferase, under 
control of the PGK promoter, the insert was digested using Bam HI and Sal I from a 
previously generated targeting vector for ADAR2 ΔECS mice (Feng et al., 2006). This 
product was ligated into pBKSII-, digested with Bam HI, blunted using the large fragment 
of DNA polymerase I (Klenow, NEB) and then digested with Xho I while the Avr II 
fragment was digested with Hpa I and Xho I; digested products were purified and ligated 
to generate a 9.3 kb fragment.  
Production of Mutant Mice 
The Vanderbilt Transgenic Mouse/ES Cell Shared Resource assisted in the 
targeting of the mouse embryonic stem (ES) cells and the generation of chimeric mice 
harboring the targeted allele. The targeting vector was linearized using a Not I restriction 
site and 129S6/SvEvTac-derived mouse ES cells were electroporated. The ES cells were 
then selected with G418 and gancyclovir. To confirm homologous recombination in 
isolated ES cell clones, PCR analysis was performed using the Expand Long Template 
PCR kit (Roche, USA) with primers designed outside the region of homology (sense, 5'-
CTGAGTGCATTGGAAAAGAGATCC-3'; antisense 5'-CCATATATCAGGATGCAGTCT 
TGTCA-3'); correctly targeted ES cell clones resulted in the amplification of a 9.3 kb PCR 
fragment due to the introduction of the 1.9 kb PGK/neomycin cassette. Two correctly 
targeted ES cell clones were expanded and subsequently microinjected into C57BL/6J 
blastocysts which were transferred to the uterus of pseudopregnant foster mothers to 
produce chimeric mice. 
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Male offspring demonstrating >70% agouti coat color chimerism were mated with 
female wild-type 129S6/SvEvTac mice and offspring from this mating were screened for 
germ-line transmission of the modified 5HT2C receptor allele by long PCR analysis. 
Animals heterozygous for the mutant 5HT2C receptor allele were mated with transgenic 
mice expressing Cre recombinase under the control of the mouse protamine 1 promoter 
(Prm-Cre 129S4/SvJae, The Jackson Laboratories, Bar Harbor, ME) (O'Gorman et al., 
1997). Progeny were screened by PCR to select for mice that had successfully excised 
the selectable marker; sequence analyses were also performed to verify locus integrity, 
presence of the introduced mutations and loss of PGK/neomycin cassette. Following 
removal of the marker, mice were backcrossed one additional generation to wild-type 
129S6/SvEvTac mice and assessed for loss of the Prm-Cre transgene using a PCR-
based strategy. Heterozygous animals that successfully eliminated the Prm-Cre 
transgene were then mated to generate animals homozygous for the mutant 5HT2C 
receptor allele.  
Given the location of the 5HT2C receptor gene on the mouse X chromosome, two 
breeding strategies were employed to generate all possible combinations of wild-type 
and INI-mutant animals; wild-type males (+/Y) were mated with heterozygous mutant 
females (INI/+) and hemizygous mutant males (INI/Y) were mated with heterozygous 
mutant females (INI/+). Resultant offspring did not differ from expected Mendelian 
distribution, indicating that the INI mutation does not result in embryonic or early-
postnatal lethality. 
Animals were housed in a humidity- and temperature controlled room on a 12-h 
light, 12-h dark cycle with ad libitum access to water and standard laboratory chow 
(rodent chow 5001; Ralston Purina Co., St. Louis, MO). 
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Analyses of genetically modified INI-mice 
RNA editing 
 For editing studies, total cellular RNA was isolated from adult mouse whole brain 
as described previously in chapter 2. The extent of editing at all five sites (A, B, C, D and 
E) was evaluated by fluorescent dideoxynucleotide based sequencing of cDNA amplified 
from mouse brain 5HT2C receptor pre-mRNA. As an additional approach to further 
examine the editing profile of 5HT2C receptor transcripts in wild-type and mutant animals, 
a 293 nucleotide (nt) segment extending from exon 5 through exon 6, containing the 
edited region of mature 5HT2C receptor transcripts, was amplified by RT-PCR from whole 
brain and the PCR reaction product was subcloned into a prokaryotic cloning vector 
(pGEM Easy-T vector; Promega, Madison, WI). Once transformed into bacteria, 10 
individual cDNA isolates from animals of each genotype were selected and sequenced. 
RNA expression and splicing 
To examine potential alterations in the level of 5HT2C receptor RNA expression, 
wild-type and INI-mutant mice were collected during a developmental time course at the 
following ages: E15, P0, P14, P21 and adult (~P100). As described previously (chapter 
2), whole brain and dissected brain regions (adult animals only) were harvested, total 
RNA was isolated and a quantitative real-time RT-PCR strategy was utilized using the 
following set of Taqman probes from Applied Biosystems Assays-on-Demand (ADAR1, 
assay ID Mm00508001_m1; ADAR2, assay ID Mm00504621_m1; 5HT2CR, assay ID 
Mm00434127_m1; 5HT1BR, assay ID Mm00439377_s1, 5HT2AR, assay ID 
Mm00555764_m1; SLC6A4, assay ID Mm00439391_m1) and eukaryotic 18S rRNA 
(product no. 4319413E) was included in each multiplex PCR as an internal control. Real-
time PCR and subsequent analysis were performed with an ABI Prism 7900HT 
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sequence detection system (SDS v2.3; Applied Biosystems, Foster City, CA); all 
reactions were run in triplicate and quantified as described previously (chapter 2). 
To measure relative expression of 5HT2C receptor mRNA splice variants in RNAs 
isolated from whole brain in wild-type and INI/Y mice, first-strand cDNA was synthesized 
as described previously (chapter 2) and then amplified with a 6-carboxyfluorescein-
labeled sense primer (5'-TATTTGTGCCCCGTCTGG-3') and a nonlabeled antisense 
primer (5'-ATCAAAGCTTGACGGCGTAGGACGTAG-3'). Resultant amplicons 
corresponding to alternatively spliced 5HT2C receptor variants were separated on a 2.5% 
agarose gel electrophoresis and fluorescence was quantified using a Typhoon 9400 
phosphorimager (Amersham Biosciences, Piscataway, NJ) with ImageQuant TL 
software. 
Protein expression 
Receptor protein levels in dissected brain regions (cortex, hippocampus and 
striatum) were determined by radioligand binding from adult wild-type and INI-mutant 
animals. Cortex, hippocampus and striatum were harvested (n=10/assay/genotype, total 
of 3 assays performed) and snap-frozen on dry ice in 24-well plates and stored at -80°C 
until the assay could be performed. The tissue was placed directly in 2 ml of cold 
standard binding buffer (SBB: 50 mM Tris-HCl, pH 7.4; 10 mM MgCl2; 1 mM EDTA), 
homogenized at ~15,000 rpm for 7 seconds and then pelleted at 25,000 x g for 10 
minutes. The supernatant was removed, 1 ml of SBB (for 1 pellet) or 2 ml of SBB (for 2 
pellets) was added, and the pellet was briefly homogenized and centrifuged in a cold 
microcentrifuge at top speed for 5 minutes. After re-pelleting, the supernatant was 
removed and the remaining pellet was placed on dry ice and stored at -80°C until ready 
for use. An 8-point saturation curve was performed in duplicate using a [3H] non-specific 
5HT2C receptor antagonist, [N6-methyl-3H]-mesulergine (concentrations: 0.25, 0.5, 1.0, 
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1.5, 2.0, 4.0, 6.0, and 8.0 nM), in the presence of 100 nM spiperone (5HT2AR 
antagonist), and 3 µM ritanserin to define non-specific binding. Assays were incubated 
for 1.5 hours in SBB at room temperature, in a 96-well format, reactions were harvested 
by vacuum filtration through glass filters washed 3 times in ice cold 50 mM Tris, pH 7.7 
and measured by liquid scintillation spectrometry. Receptor density (Bmax) and 
dissociation constant (KD) were determined by computer-assisted nonlinear regression 
analyses of saturation binding isotherms (assuming ligand depletion) using GraphPad 
Prism (GraphPad Software, Inc., San Diego, CA).  
Biogenic Amine Analysis 
In collaboration with the Vanderbilt Neurochemistry Core, biogenic amine studies 
were performed in wild-type and INI-mutant mice. Cortex, hippocampus and striatum 
(n=6/genotype) were harvested from adult mice and snap-frozen on dry ice in 1.5 ml 
eppendorf tubes. Tissue was homogenized in 0.1 M trichloroacetic acid (TCA) containing 
10 mM sodium acetate, 0.1 mM EDTA, 1µM isoproterenol (to serve as an internal 
standard), 10.5% methanol (pH 3.8) and spun in a microfuge at 10,000 x g for 20 
minutes. The supernatant was removed and stored at -80°C until the assay was 
performed and the pellet was saved for protein content using the BCA Protein Assay kit 
(Pierce, Rockford, IL). Supernatants were used to quantify the biogenic amines, 
norepinephrine (NE), dopamine (DA) and serotonin (5HT) and their metabolites, 3-
methoxytyramine (3MT), 3, 4-dihydroxyphenylacetic acid (DOPAC), 5-hydroxyindolacetic 
acid (5HIAA) and homovanillic acid (HVA) by a specific HPLC assay utilizing an Antec 
Decade (oxidation: 0.5) electrochemical detector. 20 µl of each supernatant were 
injected onto a C18 HPLC column (Phenomenex Nucleosil 5µ); biogenic amines were 
eluted with a mobile phase consisting of 89.5% 0.1 M TCA and solvent was delivered at 
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0.7 ml/min using a Waters 515 HPLC pump. HPLC control and data acquisition were 
managed by Millennium32 software (Waters Corporation, Milford, MA). 
 
Results 
 
Generation of mutant mice solely expressing the non-edited (INI) isoform of the 
5HT2C receptor 
 
To confirm that introduction of eleven point mutations in intron 5 resulted in the 
sole expression of the INI-encoding isoform of the 5HT2C receptor transcript, whole brain 
RNA was isolated from INI/Y mice, 5HT2C receptor pre-mRNA was amplified by RT-PCR 
and subjected to DNA sequence analysis. At the editing sites, double A and G peaks are 
observed in WT animals indicating the presence of both nucleotides, however only 
single A peaks are observed in INI/Y animals, revealing that only the INI isoform was 
expressed (Figure 23D). 
RNA characterization 
 
To examine potential alterations in 5HT2C expression in 5HT2CRINI mutant mice, 
we quantified the level of mature 5HT2C transcripts in RNA isolated from whole brain or 
dissected brain regions in INI/Y animals and their wild-type (+/Y) littermates. Results 
from this analysis revealed a 30-40% decrease in steady-state 5HT2C receptor mRNA in 
INI/Y mice as compared to +/Y animals (Figure 24, p<0.01, n=12). As contributions to 
this decrease in whole brain mRNA could result from larger decreases in specific brain 
regions versus a uniform decrease in whole brain, we investigated mRNA levels from 
adult animals in 3 brain regions where 5HT2C receptor mRNA is highly expressed in WT 
animal: cortex, hippocampus and striatum. In each of these brain regions, INI/Y mice 
demonstrated a 30% reduction in 5HT2C receptor transcripts when compared to their WT 
littermates, suggesting a global change in 5HT2C receptor mRNA levels (Figure 24, 
p<0.05, n=10).  
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Figure 23: Targeting strategy and generation of 5HT2CRINI mice. a) The predicted 
secondary structure for wild-type and INI-mutant pre-mRNAs in the proximal region of 
intron 5 is shown. The positions of the five editing sites (A-E) are indicated and site-
specific nucleotide alterations in intron 5, introduced to disrupt the proposed RNA 
duplex, are indicated in red lettering. b) Schematic diagram and abbreviated restriction 
map of the mouse 5HT2C receptor gene before and after targeted gene modification; the 
location of exon 5, the loxP sites (►) flanking the PGK/neomycin cassette outside the 
region of homology, the appropriate position of the introduced mutations (*) and the 
sequences outside the region of homology (dotted line) are indicated; A, Acc I; Av, Avr II; 
K, Kpn I; N, Not I; P, Pst I; S, Sfi I. c) Genotype analysis of progeny from a 5HT2CRINI 
hemizygous male x heterozygous female breeding; migration positions of PCR 
amplicons corresponding to the wild-type (201 bp) or mutant (297 bp) 5HT2C receptor 
alleles and animal genotypes are indicated. d) Sequence electropherogram traces of 
5HT2C receptor-derived RT-PCR products generated from wild-type and 5HT2CRINI 
hemizygous male mice. The positions of the five editing sites and the corresponding 
nucleotide sequences are indicated; R, purine. 
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Figure 24: INI-mutant mice display decreased mRNA in whole brain and brain 
regions. Quantitative RT-PCR analyses of 5HT2C receptor mRNA in adult whole brain 
(n=12) as well as dissected brain regions (n=10) in +/Y and INI/Y mice (mean ± SEM). *: 
p<0.05, **: p<0.01. 
 
 
To further investigate if this decreased mRNA expression was differentially 
regulated during development in INI-mutant animals, we examined total 5HT2C receptor 
mRNA levels in whole brain of animals isolated at several ages (E15, P0, P14 and P21) 
animals versus their wild-type littermates. At each developmental timepoint, 5HT2C 
receptor mRNA was decreased on average ~30% in whole brain from INI/Y animals 
versus their wild-type littermates (Figure 25). 
 
 
Figure 25: INI-mutant mice display decreased mRNA in whole brain during 
development. Quantitative RT-PCR analyses of 5HT2C receptor mRNA in developing 
whole brain (n=6) in +/Y and INI/Y mice (mean ± SEM). *: p<0.05, ***: p<0.001 
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In addition to the observed decreases in 5HT2C mRNA in INI/Y animals, we also 
quantified mRNA levels for the editing enzymes (ADAR1 and ADAR2) and several 
related genes in serotonergic pathways (5HT1BR, 5HT2AR, SLC6A4) using qPCR. In 
whole brain samples isolated from adult mice, no differences were found in the 
expression of any of these genes when comparing INI/Y animals and their WT 
littermates (Figure 26). 
 
Figure 26: INI-mutant mice do not display alterations in mRNA levels for editing 
enzymes or related serotonergic genes. Quantitative RT-PCR analyses of ADAR1 
and ADAR2 mRNA, as well as related genes in serotonergic pathways, 5HT1BR, 5HT2AR 
and SLC6A4 in adult whole brain (n=6) in +/Y and INI/Y mice (mean ± SEM). 
 
In addition to RNA editing, previous studies have shown the generation of 
multiple 5HT2C receptor isoforms through the use of alternative 5'-splice sites in exon 5 
and intron 5 (Canton et al., 1996; Wang et al., 2000b; Xie et al., 1996). Use of either the 
proximal (RNA1) or distal (RNA3) splice donor sites results in the generation of mature 
mRNAs encoding truncated receptor proteins resulting from premature translation 
termination, whereas use of the intermediate splice donor (RNA2) produces an mRNA 
species encoding the full-length, functional receptor protein (Canton et al., 1996; Wang 
et al., 2000b; Xie et al., 1996). To quantify the relative abundance of 5HT2C receptor 
mRNA splice variants in 5HT2CRINI mutant mice, we developed a quantitative RT-PCR 
based strategy utilizing 6-carboxyfluorescein-labeled (6-FAM) sense PCR primer. In 
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whole brain RNA samples isolated from adult animals, mutant mice (INI/Y) displayed a 
25% reduction in the relative expression of RNA2 and a concomitant increase in RNA1 
compared to their wild-type littermates, while no significant change in the relative level of 
RNA3 was observed (Figure 22). To determine if alternative splicing of 5HT2C receptor 
mRNA was developmentally regulated in 5HT2CRINI animals, RT-PCR was performed 
using whole brain RNA from P0 mice. While relative expression of each of the three 
splice isoforms at P0 was different than that observed in adult, the magnitude of 
difference between wild-type and INI/Y animals was the same (Figure 27). 
 
Figure 22: Altered patterns of alternative splicing in 5HT2CRINI mice. Quantification 
of relative mRNA expression for alternatively spliced 5HT2C variants in adult and P0 +/Y 
(black bars) and INI/Y (white bars) mice. The relative level of each mRNA isoform is 
expressed as a percentage of total 5HT2C receptor transcripts (n = 6, mean ± SEM). ***: 
p<0.001. 
 
Protein expression 
 
Given the altered mRNA expression and splicing patterns observed in INI/Y 
animals, we assessed whether the INI mutation would also result in changes in total 
5HT2C receptor protein expression using radioligand binding assays in cortex, 
hippocampus and striatum from adult +/Y and INI/Y male mice and +/+, INI/+ and INI/INI 
females. As predicted by the observed decreased in mRNA expression, 5HT2CRINI mice 
displayed a genotype-dependent reduction in total 5HT2C receptor protein expression in 
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all brain regions examined (Figure 28). In cortex, hemi- and homozygous mutant mice 
displayed a 50-65% reduction in 5HT2C receptor protein as compared to their wild-type 
littermates, while INI/+ mutants demonstrated a reduction of about 25%. Similarly, 
protein expression was also reduced in the hippocampus and striatum, yet the effects 
were more pronounced. Analysis of 5HT2C receptor protein in hippocampal samples 
revealed a 65 and 75% decrease in INI/INI and INI/Y mice, respectively, while INI/+ mice 
showed a 40% reduction in 5HT2C receptor protein as compared to wild-type littermates. 
In striatum, there was a 60-70% reduction in 5HT2C receptor protein in INI/Y and INI/INI 
mice, with little to no change (~5%) observed in INI/+ mutant animals. 
 
Figure 28: 5HT2CRINI mice show decreased 5HT2C receptor protein. Summary of 
saturation binding analyses for 5HT2C receptor expression in dissected cortex, striatum 
and hippocampus for adult wild-type (+/Y and +/+) and mutant (INI/Y, INI/+, INI/INI) mice 
are presented. Maximal binding (Bmax) is expressed as a percentage of wild-type values 
for each gender (n = 3 groups of 10 pooled brain regions, mean ± SEM) *: p<0.05, **: 
p<0.01, ***: p<0.001. 
 
Biogenic Amine Analysis 
In collaboration with the Vanderbilt Neurochemistry Core, we measured the 
levels of the biogenic amines (NE, 5HT, DA) and their metabolites (3MT, DOPAC, HVA, 
5HIAA) in wild-type and 5HT2CRINI adult animals in cortex, hippocampus and striatum. 
We observed minor region-specific changes in biogenic amine levels with increased 
levels of DA in INI/Y mice as compared to their wild-type littermates in striatum (p<0.05, 
2-way ANOVA) (Figure 29). We also observed increased DA levels in INI/INI mice as 
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compared to wild-type littermates in cortex (p<0.05, 2-way ANOVA) (Figure 29). No 
other significant differences were seen with additional amines in the remaining brain 
regions analyzed. 
 
Figure 29: Biogenic amine analysis revealed differences in DA levels. INI/Y male 
mice have increased DA levels in striatum compared to wild-type male littermates (n=6, 
mean ± SEM) while INI/INI female mice have increased DA levels in cortex compared to 
their wild-type female littermates (n=6, mean ± SEM). *: p<0.05. 
 
 
Discussion 
 
The editing of the 5HT2C receptor transcripts has been shown to modulate 
multiple aspects of receptor signaling, trafficking and expression in heterologous 
systems, yet the physiologic relevance of 5HT2C receptor editing has been unexplored. 
Genetically-modified mice solely expressing the non-edited isoform of the 5HT2C 
receptor show a 30% reducution in steady-state 5HT2C receptor mRNA (Figures 24 and 
25) and a 50-75% decrease in receptor protein expression (Figure 28). Beacause the INI 
isoform of the 5HT2C receptor has been shown to display increased constitutive activity 
and G-protein coupling relative to more highly edited isoforms (Burns et al., 1997; 
Niswender et al., 1999; Niswender et al., 1998), the decreased levels of 5HT2C mRNA 
and receptor levels may represent an adaptive compensatory alteration to maintain 
normal levels of receptor signaling. Previous pharmacologic studies have suggested that 
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5HT2C receptor editing represents a homestatic mechanism to retain the basic response 
properties of 5HT2C receptors in the face of changing synaptic input to maintain receptor 
activation (Gurevich et al., 2002a; Schmauss, 2005). Disparities between the observed 
decrease in receptor mRNA and protein levels may be further explained by alterations in 
5HT2C alternative splicing patterns, as mutant mice show a 25% reduction in synthesis of 
RNA2 (Figure 27), the mRNA isoform responsible for generating the full-length, 
functional receptor protein. Recent studies have indicated that the alternative splicing of 
5HT2C receptor pre-mRNAs can be regulated by editing at the E, C and D sites to 
promote the expression of RNA2 (Flomen et al., 2004), consistent with the observed 
increase in RNA1 at the expense of RNA2 for non-edited transcripts in mutant mice 
(Figure 27). 
It is important to note that saturating binding analyses with total membrane 
proteins may underestimate the degree of compensation that occurs due to the fact that 
such techniques detect total 5HT2C receptor binding, rather than receptors localized to 
the cell surface. Recent studies have indicated that cell surface expression of the 5HT2C 
receptor decreased in parallel increased constitutive activity (decreased editing) of the 
receptor (Marion et al., 2004); the subcellular distribution of the non-edited (INI) and 
highly edited (VSV and VGV) isoforms was dependent on their ability to interact with β-
arrestin2, which correlated with the constitutive activity level of each isoform. 
Despite the observed decrease in 5HT2C receptor expression in mutant mice, we 
did not observe any changes in other components of the 5HT system including the 
5HT1B and 5HT2A receptors and the serotonin transporter (SLC6A4) at the mRNA level 
(Figure 26). Such changes are not necessarily surprising given that 5HT2C receptor KO 
animals do not display any significant alterations in these components of 5HT signaling 
(Lopez-Gimenez et al., 2002). We also do not observe any alterations in levels of 5HT or 
5HIAA in 5HT2CRINI mutant animals; we do observe changes in DA levels in striatum and 
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cortex of INI/Y and INI/INI animals (Figure 29). These changes in DA levels appear to be 
regional as well as gender-specific so it is unclear what role, if any, these alterations 
may have. It is possible that INI-mutant mice have increased stores of DA, so future 
studies should address this. Nevertheless, these changes do implicate that the DA 
system is closely regulated with the 5HT system. Taken together, the observed 
alterations in 5HT2C receptor mRNA, protein, alternative splicing and DA levels in mutant 
mice that solely express the non-edited isoform of the 5HT2C receptor emphasize the 
importance of RNA editing in the CNS. 
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CHAPTER IV 
 
 
PHENOTYPIC ALTERATIONS IN 5HT2CRINI DAMS 
 
 
Introduction 
 
Previous studies in heterologous cell systems have revealed differences in the 
efficacy of receptor:G-protein coupling between edited 5HT2C receptor isoforms, yet the 
physiological relevance of this differential signaling has yet to be examined in an animal 
model system. Since the INI isoform of the 5HT2C receptor exhibits the greatest basal 
activity and agonist potency via enhanced G-protein coupling (Berg et al., 2001; Herrick-
Davis et al., 1999), we hypothesized that mutant mice bearing the INI allele would show 
enhanced signaling capacities compared to wild-type (WT) animals. 5HT2C receptor-null 
mice have abnormalities in feeding behavior, seizures, learning and memory, anxiety 
and cocaine abuse (Nonogaki et al., 1998; Rocha et al., 2002; Tecott et al., 1998; Tecott 
et al., 1995) highlighting potential systems in which physiologic alterations may be 
observed. In mice solely expressing the INI isoform of the 5HT2C receptor, an 
unanticipated deficit in maternal behavior was observed and phenotypic 
characterizations has focused upon altered behaviors in both dams and offspring 
(Chapter 5). 
Maternal behaviors are defined as a series of events (e.g. nest building, pup 
retrieval, nursing) that are required for offspring survival and subsequent behavioral 
states in the offspring (Kuroda et al., 2007). The initiation and maintenance of maternal 
behaviors is regulated by a complex series of events that includes modulating hormonal 
balance in the dam prior to and immediately following delivery, as well as interaction with 
pups from birth until weaning. Early maternal behavior is controlled by hormones 
associated with parturition, particularly the protein hormones oxytocin and prolactin 
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(Theodosis et al., 2004; Wettschureck et al., 2004). Both of these hormones are required 
for effective nursing of young pups. Female oxytocin-null mice are unable to lactate and 
therefore their young must be cross-fostered to survive (Nishimori et al., 1996). 
Disruption of the prolactin gene causes infertility and an inability to lactate, but does not 
prevent mice from nurturing their young (Horseman et al., 1997). Interestingly, many 
prolactin-releasing factors such as thyroid-stimulating hormone (TRH) and oxytocin act 
through Gαq/11-coupled receptors (Aragay et al., 1992; Freeman et al., 2000; Gimpl and 
Fahrenholz, 2001) and a forebrain-specific double knockout mouse for Gαq/11 displays 
deficits in maternal behaviors such as nest building and pup retrieval (Wettschureck et 
al., 2004). 5HT2C receptors preferentially couple to Gαq, thus providing a potential link 
between endogenous signaling pathways and behaviors observed in 5HT2CRINI mice. 
Maternal behavior is also influenced by the limbic system. Activation of c-fos, a 
marker of neuronal activation, is often seen in brain regions important for the 
development and maintenance of maternal behaviors including medial preoptic area of 
the hypothalamus (MPOA), nucleus accumbens (NAc), bed nucleus of the stria 
terminalis (BNST), basolateral amygdala (BLA) and prefrontal cortex (PFC) (Fleming 
and Korsmit, 1996; Fleming et al., 1994; Numan et al., 2005; Sheehan et al., 2001; 
Stack et al., 2002; Stack and Numan, 2000). Reinforcement of maternal behaviors also 
depends on other limbic pathways, including the amygdala-nucleus accumbens 
pathways, a pathway important in rewarding behaviors (Fleming et al., 1994). Systemic 
administration of DA antagonists disrupts both ongoing maternal behavior (Giordano et 
al., 1990) and development of conditioned place preference to pup stimuli (Fleming et 
al., 1994). Recent studies using functional magnetic resonance imaging (fMRI) have 
further demonstrated that suckling stimulation in lactating dams activated the DA reward 
system. When lactating mothers were given cocaine, the resultant activation of these 
reward pathways was suppressed, indicating that pup stimulation was more reinforcing 
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than cocaine (Ferris et al., 2005). It has been suggested that activation of 5HT2C 
receptors may substantially contribute to a serotonergic inhibition of mesolimbic DA 
activity (Di Giovanni et al., 2000; Gobert et al., 2000); activation of the mesolimbic DA 
system is considered critical for the reinforcing and psychostimulant effects of cocaine 
(Wise, 1984) and thus provides a potential link between alterations in the 5HT2C receptor 
system and maternal behavior. 
 
 
Experimental Procedures 
 
Behavior 
 All procedures were approved by the Vanderbilt Institutional Animal Care and 
Use Committee and complied with Public Health Service Policy on the humane care and 
use of laboratory animals. 
Rearing paradigms: cross-fostering and aunting 
For cross-fostering studies, wild-type and heterozygous mutant (INI/+) female 
mice were mated with wild-type and hemizygous mutant (INI/Y) males, respectively. On 
P0, entire litters were exchanged between dams of different genotypes and litters were 
checked daily for pup survival. Beginning at P7, pups were marked and weighed daily 
until weaning on P21. 
For behavioral studies requiring pups raised by communal nesting, separate 
groups of wild-type female mice were mated with wild-type males or hemizygous mutant 
(INI/Y) males. When females were visibly pregnant (~E18), wild-type and INI/Y-mated 
dams were placed in the same cage and allowed to cooperatively and communally raise 
their offspring, thereby allowing both wild-type and INI/+ female littermates to be reared 
by wild-type dams. 
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Nest building 
For quantification of nest building behavior, individually housed multiparous, 
pregnant dams (wild-type and INI/+; E19) were provided a 5 x 5 cm piece of 
commercially available cotton nesting material (Ancare, Bellmore, NY) 90 minutes prior 
to the start of the dark cycle. At the end of the dark cycle, 12 hours later, a final 
estimation of the percentage of nesting material chewed, as well as nest depth at the 
thickest part of the nest, were recorded. The quality of nest building by wild-type and 
INI/+ dams were rated according to a 5-point scale developed by Lisk (Lisk et al., 1969) 
where: 0=no nest; 1=nest material in the corner of the cage; 2=some organization of 
nest material; 3=nest with semi-circular walls; 4=full nest with tall walls. 
Maternal care and pup retrieval 
Pup retrieval assays were conducted 8 hours after the onset of the light cycle in 
postpartum, multiparous dams (wild-type and INI/+; P0). Pups were removed and kept 
warm for a 1 hour period. Shortly before reunion of dams with offspring, the dam was 
removed from the cage and 3 of her own pups were placed into the corners, away from 
the nest. The dams were placed back in the cage with their pups and assayed for 
latency to approach the first pup as well as the total time to retrieve all pups into the nest 
(Brown et al., 1996). Retrieval was defined as picking up the pup and moving it into the 
nest; a pup that was picked up and then dropped was not classified as a successful 
retrieval event. Total time for completion of the retrieval task was limited to 15 minutes. 
For pharmacologic rescue studies, pups were removed from newly postpartum 
dams as described above and dams were administered either vehicle (0.9% saline) or 
the 5HT2C receptor inverse agonist, 3,5-dihydro-5-methyl-N-3-pyridinylbenzo[1,2-b:4,5-
b’] dipyrrole-1(2H)-carboxamide hydrochloride (SB206553; 5mg/kg body weight, Tocris 
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Bioscience, Ellisville, MO), by intraperitoneal injection one hour prior to retrieval testing. 
Retrieval studies were then performed as described above. 
Locomotor activity 
Locomotor activity was assayed using a commercially-available open field arena 
(ENV-520, MED Associates) measuring 27 x 27 x 20 cm with clear Plexiglas walls and 
white floors. Infrared detectors determined the mouse’s position every 50 milliseconds 
(msec) and automatically recorded and analyzed distance traveled, rearings, circling, 
etc., in the open field.  
Elevated Plus Maze 
Anxiety-related behaviors were assayed using an elevated plus maze (EPM). 
This apparatus is plus-shaped consisting of two closed arms (platforms with tall walls) 
and two open arms (platforms with no walls) connected by a small center square (5 x 5 
cm) built on 40 cm high legs and placed on the floor for testing. All arms measured 30 
cm long x 5 cm wide with white Plexiglas floors; closed arms had 15 cm high walls made 
of black Plexiglas, while open arms were lined with a 0.25 cm white Plexiglas edge to 
decrease the likelihood of the mouse falling off the maze. Four white screens were 
placed around the maze to reduce spatial cues from the room and a white noise 
generator was present in the room for all experiments. A camera was placed directly 
above the maze to record the behavior of each animal. 
For all experiments, individual animals were placed in center of the maze and 
permitted to freely explore for five minutes. The maze was illuminated in dim lighting 
conditions (~60 lux) to increase the likelihood of exploring the maze. Measurements 
were performed by investigators blind to genotype who hand coded the videotaped 
behavior using ProcoderDV (Vanderbilt University, Nashville, TN). The number of entries 
into the open and closed arms, duration spent in arms and the center of the maze was 
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also measured for each animal. Entries and exits from maze arms were defined as all 
four paws crossing into or out of an arm. 
Novelty 
 To assess the response to a novel object, multiparous female dams were placed 
into a test cage for five minutes. At the end of a five minute habituation period, a 15mL 
conical tube (novel object) was introduced. Mice were permitted to explore the novel 
object for 10 minutes and behavior was recorded. Latency to approach novel object as 
well as time spent assessing the object was scored. 
Olfaction 
 To assess whether mutant mice were anosmic, assays of olfaction were 
performed by placing multiparous female dams into a test cage for five minutes for 
habituation. After 5 minutes, the mouse was briefly removed and a single chocolate chip 
was hidden in the bedding. The mouse was then returned to the test cage and the 
latency to approach the newly introduced scent and dig it up was recorded. 
 
Mammary gland morphology 
 Inguinal mammary glands were harvested bilaterally at various stages of 
development including virgin, lactation day 1 (L1), lactation day 7 (L7) and involution. For 
nipple disconnection studies, virgin female mice underwent surgery to disconnect the left 
fourth inguinal gland at 10 weeks of age prior to breeding. After surgically disconnecting 
the nipple, glands were separated from the proximal connective mesenchyme 
associated with the adjacent dermis. The blood supply between the fourth and fifth 
inguinal gland was cauterized and the two glands were surgically separated. The fourth 
inguinal gland was then allowed to retract toward the distal region prior to closing. The 
distal region of the fourth inguinal mammary gland and associated vasculature remained 
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intact and attached to the adjacent mesenchyme during the procedure. 10 days after the 
procedure, mice were mated and both inguinal glands were collected from L1 dams. 
Harvested glands were fixed in 10% neutral buffered formalin overnight at 4°C. 
Following fixation, glands were transferred to 70% ethanol then sectioned (5uM) for 
subsequent Hematoxylin and Eosin (H&E) staining and histopathological analyses. H&E 
stained sections were visualized on an AxioplanII microscope and Axiocam HR (Carl 
Zeiss, Thornwood, NY). Images were digitally captured using Axiovision (4.1) software 
and exported as TIFF files for subsequent analysis. 
 
Quantitative analysis of mRNA transcripts associated with parturition 
 To examine potential changes in prolactin and oxytocin mRNA, pituitary gland 
and hypothalamus were harvested from dams on lactation day 1 (L1). Total RNA was 
isolated as described in Chapter 2 and a quantitative real-time RT-PCR strategy was 
utilized using specific Taqman probes (prolactin, assay ID Mm00599957_m1; oxytocin, 
assay ID Mm00726655_s1). 
 
Statistical Analyses 
All statistical analyses were performed using GraphPadPRISM (GraphPad 
Software, Inc., La Jolla, CA). For comparisons between 2 groups, Student’s t-test was 
performed; comparisons between 3 or more groups utilized one-way analysis of variance 
with appropriate post-hoc tests as indicated. Values are reported as means ± SEM, and 
P values of <0.05 were considered significant. 
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Results 
 
Growth in INI/+ reared offspring 
 
Initial observations of home cage behavior for INI/+ dams identified lethality for 
offspring born to mutant dams, yet a normal Mendelian ratio for pups was observed at 
weaning. To distinguish between neonatal lethality associated with altered maternal 
behavior and phenotypic changes in mutant offspring, we took advantage of a selective 
breeding strategy in which wild-type females were mated to INI/Y males and INI/+ 
females were mated to wild-type males, allowing both wild-type and INI/+ dams to raise 
mixtures of wild-type and mutant offspring. Following birth, litters were culled to five pups 
and the growth rates of offspring were monitored daily from P7 through weaning (P21). 
Both wild-type and mutant offspring raised by INI/+ dams weighed significantly less than 
offspring raised by wild-type femeales (Figure 30A), indicating that the observed deficits 
in growth rate resulted from an altered maternal environment rather than genotype-
dependent growth deficits in the offspring themselves.  
To eliminate the possibility that differences in intrauterine environment might 
explain the delayed growth rate for INI/+-raised offspring, we also employed a cross-
fostering paradigm in which mice were bred using the same selective breeding 
paradigm, but within 2 hours of birth, entire litters were cross-fostered between wild-type 
and INI/+ dams. Results from this litter manipulation revealed a significant decrease in 
the number of pups that survived beyond P3 when raised by INI/+ dams (60.5%) as 
compared to wild-type dams (94.3% survival) (Figure 30B). Furthermore, a decrease in 
the weight of the surviving offspring fostered to INI/+ dams (8.3±1.3g for wild-type-reared 
offspring versus 7.6±0.4g for INI/+-reared offspring; n≥23, p<0.001) was observed. To 
assess long-term effects on offspring growth, male and female offspring were generated 
using the selective breeding strategy; pups were separated at weaning, housed with 
littermates of the same gender and weights were monitored weekly from P21 through 
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P84. Although no difference in pup body weight was observed at birth, both wild-type 
and mutant male offspring born to INI/+ dams displayed a 14.5% decrease in body mass 
by weaning and an 18% decrease in body mass by P84 (Figure 30C, left). Growth 
differences were also observed for female offspring born to INI/+ dams, though the 
effects were less pronounced (Figure 30C, right). These long-term alterations in growth 
observed in offspring of INI/+ dams indicate that early maternal envirornment can lead to 
subsequent growth disparities in adult animals.  
 
Figure 30: Growth deficits and neonatal lethality for offspring reared by INI/+ 
mutant dams. a) Pre-weaning growth curves are shown for litters culled to 5 pups at P0 
for mixed gender offspring resulting from either the breeding of hemizygous mutant 
males x wild-type females (●) or wild-type males x heterozygous mutant females (   ). (n 
= 20 pups for each breeding strategy; mean ± SEM, p<0.0001). b) Survival curves for 
mixed gender offspring cross-fostered at P0 to wild-type dams (●, n=28 pups) and wild-
type offspring cross-fostered at P0 to heterozygous mutant dams (   .n=35 pups). c) 
Post-weaning growth curves of selectively bred male (left) and female (right) offspring 
reared by +/+ and INI/+ dams (n≥5 pups for each pup/dam combination, mean ± SEM, 
p<0.0001 for all curves by two-way ANOVA). 
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Mammary gland morphology in INI/+ dams 
To determine if the failure to thrive phenotype in offspring raised by INI/+ dams 
was related to an inability to nourish the pups, we sought to determine if +/+ and INI/+ 
dams differed in their mammary gland structure and hence their ability to lactate. No 
anatomical differences between the inguinal mammary glands of virgin +/+ and INI/+ 
mice were observed. Females were then mated and the inguinal glands were harvested 
on the first and seventh day of lactation (L1 or L7). On L1, +/+ mammary glands 
contained ~50% ductal and alveolar structures (Figure 31A), however mammary glands 
harvested from L1 INI/+ dams contain ~80% ductal and alveolar structure (Figure 31E). 
Further examination at higher magnification revealed that INI/+ dams had few lipid 
droplets within the alveolar lumen and epithelial cells (Figure 31F) when compared to 
wild-type tissue (Figure 31B). However, examination of +/+ and INI/+ dam mammary 
glands reveal no differences by L7. 
Since alterations in mammary gland structure can be the result of dam behavior 
(decreased time spent with pups, decreased pup suckling) or biochemical alterations in 
the dam, we surgically disconnected one inguinal gland in virgin females and allowed 
them to recover from surgery before mating. At L1, both inguinal glands were harvested 
and processed for H&E staining. The non-disconnected nipple (suckled nipple) revealed 
the previously observed differences between +/+ (Figure 31D) and INI/+ dams (Figure 
31H) with few lipid droplets present in mutant animals. However, the disconnected nipple 
(unsuckled nipple) was identical between the two genotypes (Figure 31C and G), 
suggesting that the hormonal and biochemical circuitry necessary to establish normal 
gland morphology was intact.  
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Figure 31: INI/+ mutant mice demonstrate altered mammary gland morphology. At 
lactation day 1, H & E staining of inguinal glands reveals vast differences between INI/+ 
mutant females and their wild-type littermates (n=6). Under low powered magnification, 
INI/+ mutant mammary glands (e) are comprised of approximately 80% aveoli and ductal 
structures as compared to wild-type glands (a) which contain 50% aveoli and ductal 
structures suggesting increased lactogenesis in INI/+ mutant mammary glands. At high 
powered magnification, INI/+ mutant females (f) have a noticeable lack of lipid within the 
aveoli and lumen as compared to wild-type littermates (b). H & E staining of inguinal 
glands from the unsuckled nipple reveal no differences between wild-type (c) and INI/+ 
(g) dams while suckled nipple (d) displays characteristics of increased lactogenesis and 
lack of lipid in INI/+ dams (h). 
 
 
Changing levels of prolactin and oxytocin at parturition have been implicated in 
their role in nurturing behaviors (Bridges, 1994; Rosenblatt et al., 1988). Suckling activity 
by pups leads to the release of prolactin, to stimulate production of milk (lactogenesis), 
and oxytocin, which triggers milk let-down (Figure 32) (Hansen and Gummesson, 1982; 
Juss and Wakerley, 1981). To determine whether alterations in prolactin or oxytocin 
expression between +/+ and INI/+ dams could explain the observed differences in 
mammary gland morphology or the failure to thrive observed in the offspring, we used 
qPCR to quantify prolactin (PRL) and oxytocin (OXY) mRNA levels in pituitary and 
hypothalamus, respectively, harvested from L1 dams. Results from this analysis 
revealed no difference in the levels of PRL and OXY transcripts in +/+ and INI/+ dams 
(Figure 33). 
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Figure 32: Schematic representation of the role of prolactin and oxytocin in milk 
production and letdown. Suckling behavior of the pup triggers the release of prolactin 
and oxytocin from the pituitary and hypothalamus, respectively. Prolactin binds to its 
receptors in the mammary gland to stimulate the production of milk while oxytocin acts 
on the mammary gland to produce milk ejection. 
 
 
 
Figure 33: Prolactin and oxytocin mRNA levels in +/+ and INI/+ mutant dams. 
Quantitative PCR analysis of prolactin (PRL) and oxytocin (OXY) mRNAs isolated from 
pituitary gland and hypothalamus, respectively, of L1 dams is presented for +/+ (black) 
and INI/+ mutant (white) dams (n=8, p>0.05). 
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General behavior of INI/+ dams 
To assess potential behavioral alterations in anxiety-related behavior or 
locomotor activity in INI/+ dams that accompany the abnormal maternal behavior, we 
assessed the behavior of wild-type and heterozygous mutant dams. Analyses of a 60 
minute open-field exposure revealed that INI/+ dams did not differ from their wild-type 
littermates in total distance traveled (Figure 34A). To measure anxiety-related behaviors, 
we used the elevated-plus maze (EPM) task. +/+ and INI/+ dams did not differ in the 
amount of total entries or entries into either arm of the maze, but INI/+ dams spend less 
time in the closed arms (Figure 34B) with corresponding increased time in the center of 
the maze. 
 
 
 
 
Figure 34: Behavioral analyses of +/+ and INI/+ dams. a) Activity behavior assessed 
by open field analysis is presented for +/+ (black) and INI/+ (white) dams; the total 
distance traveled in 60 minutes is presented (mean ± SEM, n=10 for each genotype). b) 
Elevated plus maze analysis of anxiety-like behavior is presented for +/+ (black) and 
INI/+ (white) dams; the percentage of time spent in the closed and open arms as well as 
the center portion of the maze is presented (mean ± SEM, n=10 for each genotype 
*:p<0.05 by Student’s two-tailed t-test). 
 
 
To control for the influence of an olfactory or exploratory deficit on the disruption 
of maternal care, we also assessed INI/+ mice for deficits in olfaction and their response 
to novel objects. +/+ and INI/+ females also did not differ in the latency to approach a 
novel object (Figure 35A) or in the percentage of total time spent investigating the object 
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(+/+: 45.4 ± 1% versus INI/+: 45.5 ± 0.4%, p>0.05). +/+ and INI/+ mice also did not differ 
in the latency to discover a chocolate chip buried within the bedding (Figure 35B), 
suggesting that olfactory and exploratory deficits do not play a role in the observed 
disruption of maternal care in 5HT2CRINI dams. 
 
. 
 
Figure 35: INI/+ mutant dams show normal responses to novel objects and 
olfactory cues. a) Latency to approach a novel object is presented for +/+ (black) and 
INI/+ (white) dams (mean ± SEM, n=6 for each genotype, p>0.05). b) Latency to find a 
hidden olfactory cue is presented for +/+ (black) and INI/+ mutant (white) dams (mean ± 
SEM, n=6 for each genotype, p>0.05). 
 
Maternal behavior in INI/+ dams 
 
After ruling out obvious anatomic or physiologic alterations as potential 
explanations for the observed deficits in maternal behavior, we next examined potential 
alterations in nurturing of the dams. In rodents, nurturing behavior is quite stereotyped 
and includes nest building, cleaning the pups, retrieving them to the nest and crouching 
over them to nurse (Barnett and Burns, 1970). Observations of home cage behavior 
revealed that offspring born to INI/+ dams were found scattered around the cage (Figure 
36A) rather than huddled beneath the dams and INI/+ dams failed to remove placental 
membranes and groom pups following birth. To assess futher dimensions of maternal 
care, we compared nest-building behavior between wild-type and 5HT2CRINI mice. Wild-
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type and INI/+ multiparous pregnant (E18) females were provided with cotton nesting 
material 90 minutes prior to onset of the dark cycle and photographs were taken 24 
hours later to quantify nest quality. Nests prepared by INI/+ dams were not only of 
reduced quality compared to wild-type dams, but also 80% of INI/+ dams failed to chew 
the nesting material (Figure 36B). 
 
 
 
 
Figure 36: INI/+ mutant dams demonstrate altered maternal behaviors. a) 
Representative photograph of an INI/+ mutant dam with scattered pups shortly after 
giving birth (P0). b) The quality of nest building was assessed (n=6, mean ± SEM) and 
representative photographs of nests taken 24 hours after addition of a cotton nestlet to 
the cages of mice are presented for +/+ and INI/+ mutant dams. 
 
 
To assess another aspect of maternal behavior, pup retrieval behavior was 
examined in wild-type and INI/+ dams. The latency to approach the first pup was 
significantly less (p<0.001) for wild-type dams (29±18 seconds; n=6) compared to INI/+ 
mothers (418±289 seconds; n=6). All wild-type dams successfully retrieved three pups 
each, wheras only one mutant dam retrieved all of her pups and the remaining INI/+ 
dams failed to retrieve a single pup (Figure 37), indicating a severe disruption in 
maternal retrieval behavior. 
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Altered behavior could result from signaling changes in 5HT2CRINI mice since this 
isoform displays the greatest level of constitutive activity and G-protein coupling efficacy 
(Niswender et al., 1999). To determine if decreased retrieval was related to an alteration 
in 5HT2C receptor signaling, we attempted to rescue pharmacologically the pup retrieval 
deficit in INI/+ dams by treatment of newly postpartum females with a 5HT2C receptor 
inverse agonist. Dams were treated with SB206553 (5mg/kg, IP) or vehicle following 
removal of pups from the cage; after 1 hour of separation, pup retrieval behavior was 
assessed. As observed previously, wild-type dams retrieved all of their pups even in the 
presence of the inverse agonist, but unlike vehicle-treated INI/+ dams that did not 
retrieve a single pup, all treated INI/+ dams retrieved at least two of three offspring 
(Figure 37). 
 
 
 
 
Figure 36: Retrieval deficits in INI/+ dams can be rescued with treatment of a 5HT2C 
receptor inverse agonist. The number of pups retrieved by wild-type and INI/+ dams 
within 15 minutes is presented for untreated (n=6), vehicle-treated (n=3) or inverse 
agonist-treated (SB206553, 5mg/kg; n=4). Data was analyzed by Friedman’s non-
parametric two-way ANOVA (p<0.05). 
 
 
Discussion 
 
As compared to wild-type dams, heterozygous mutant dams display deficits in 
maternal care including failure to build nests, to clean pups at birth or to retrieve 
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scattered pups (Figures 36 and 37). Offspring born to dams demonstrating poor 
maternal care often have decreased survival and growth rates (Brown et al., 1996; 
Thomas and Palmiter, 1997) as well as long-term behavioral deficits (Champagne and 
Meaney, 2001; Meaney, 2001).   
Accordingly, the offspring of 5HT2CRINI dams have both decreased survival and 
those that survive demonstrate long term effects of maternal neglect including early 
growth rate deficits (Figure 30A) that continue throughout adulthood (Figure 30C and D). 
Cross-fostering studies revealed that wild-type offspring fostered to INI/+ dams had a 
decreased survival rate (Figure 30B) as well as decreased body weight compared to 
those raised by wild-type dams, confirming that the alterations in growth are due to poor 
maternal care rather than the genotype of the pups. Failure to thrive can lead to long-
term growth deficits in offspring as well as higher incidences of behavioral abnormalities 
(Black et al., 2007; Oates et al., 1985). The early quality of care that offspring receive 
can also have long-term effects in later life; individuals raised in environments with 
poorer maternal care develop vulnerability to illness throughout later life (Taylor and 
Seeman, 1999), are at greater risk for mental illness (Bifulco et al., 1991), diabetes and 
heart disease (Felitti et al., 1998).  
If the INI mutation caused abnormal mammary gland function, it could be 
responsible for the failure to thrive phenotype observed in offspring of INI/+ dams. No 
differences in the morphology of the inguinal mammary glands were observed in virgin 
females, but inguinal glands harvested from dams at L1 revealed that the glands from 
INI/+ dams had increased aveoli and ductal structures (Figure 31E) as well as 
decreased lipid droplets (Figure 31F). These differences could not be attributed to 
altered biochemical circuits within INI/+ dams (Figure 31C, D, G and H) or prolactin or 
oxytocin transcript levels within the pituitary and hypothalamus, respectively (Figure 33). 
Since surgically disconnected nipples of INI/+ dams appeared normal at L1, it is most 
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likely that these morphological differences are due to decreased suckling by the pups as 
a result of poor maternal care, rather than direct alterations in structure/function of the 
mammary glands caused by the gene mutation. We did not directly measure suckling 
time by the pups; however it has been demonstrated in other models of poor maternal 
care that the extreme maternal neglect is often accompanied by less time spent on the 
nest as well as decreases in nursing time (Brown et al., 1996; Thomas and Palmiter, 
1997). 
Maternal neglect and nurturing deficits are observed in other mutant mouse 
models [for a review see: (Gammie, 2005)] suggesting that a common neural circuit 
underlies these behaviors. Sensory abnormalities can lead to possible nurturing defects 
as the processing of olfactory cues has been shown to be critical for pup retrieval 
(Smotherman et al., 1974). The main olfactory bulb appears to be the key mediator for 
olfactory signals as lesions of the accessory olfactory system has no effect on maternal 
care (Jirik-Babb et al., 1984; Lepri et al., 1985). Our mice performed normally on an 
olfaction assay demonstrating that, at the least, they are able to detect their pups (Figure 
35B). Highly anxious animals or animals which have either heightened or reduced 
responsiveness to novelty also sometimes display abnormal maternal behavior. Inbred 
strains of mice often vary in their quality of maternal care, for example, as compared to 
C57BL/6J dams, BALB/cJ dams spend less time in the nest, exhibit less licking and 
grooming of pups and display less time nursing pups (Anisman et al., 1998; Carlier et al., 
1982). These mouse strains also differ in their anxiety-like states with BALB/cJ mice 
displaying increased levels of anxiety (Falls et al., 1997; Hackler et al., 2006; Yilmazer-
Hanke et al., 2003) and elevated glucocorticoid responses to stress (Anisman et al., 
1998; Shanks et al., 1990; Tannenbaum et al., 2003) suggesting that anxiety-like states 
alter the quality of maternal care. However, INI/+ mice do not display alterations in 
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anxiety as measured by the EPM or differences in response to a novel object test 
(Figures 34 and 35A).  
Another possible explanation for poor maternal care is disruption of the circuitry 
that mediates reward. Postpartum dams will bar press for pups in an operant response 
paradigm at a higher-rate than virgin animals (Lee et al., 2000), will cross electric grids 
to receive pups and will choose pups over food (Fahrbach and Pfaff, 1982). Dams will 
also develop conditioned place preference to pup stimuli (Fleming et al., 1994). 
However, these behaviors are dependent upon the dam’s maternal state as non-
maternal virgins often will not exhibit these behaviors (Fleming and Luebke, 1981; 
Fleming et al., 1994). Administration of DA antagonists disrupt both ongoing maternal 
behavior (Giordano et al., 1990) and infusions of 6-hydroxydopamine (6-OHDA), a 
neurotoxin that destroys catecholaminergic neurons, into lactating rat dams results in 
deficits in pup retrieval (Hansen et al., 1991). Observations that the retrieval behavior of 
5HT2CRINI mutant dams can be rescued with a selective 5HT2C receptor inverse agonist 
(SB206553) indicate that the observed deficits in retrieval behavior result from increased 
5HT signaling (Figure 37) rather than reduced 5HT2C expression. Interestingly, 
SB206553 has been shown to increase DA release in nucleus accumbens and striatum 
in vivo (Berg et al., 2005; De Deurwaerdere et al., 2004), presumably modulating a 
negative serotonergic tone on mesolimbic DA activity (Gobert et al., 2000) via 
GABAergic interneurons (Eberle-Wang et al., 1997). Therefore, we postulate that the 
disruption of normal maternal behavior observed in INI-mutant dams may be due to 
excess constitutive activity of non-edited 5HT2C receptors, which leads to abnormal DA 
signaling. This represents a novel role for RNA editing of the 5HT2C receptor in the 
regulation of serotonergic control over reward behavior and highlights the necessity for 
expressing multiple, edited isoforms for normal nervous system function. 
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CHAPTER V 
 
 
PHENOTYPIC ALTERATIONS IN OFFSPRING OF 5HT2CRINI DAMS 
 
 
Introduction 
 
Early social experiences can have long-term behavioral and emotional 
consequences in mammals, including non-human primates and rodents. In the 1960s, 
Harlow et al. demonstrated that total social deprivation throughout infancy usually results 
in behavioral abnormalities and severe social and emotional deficits, especially evident 
in aggressive, reproductive and parenting activities (Harlow et al., 1965). In both 
primates and rodents, infants deprived of maternal care, either as the result of complete 
maternal deprivation or neglect, exhibit increased fearfulness, inappropriate and often 
excessive aggressive patterns of social behavior and impaired cognitive development 
(Ladd et al., 2000; Suomi, 1997). The decreased mother-infant contact, resulting from 
extended periods of maternal separation, seems likely to be critical for the effects on 
development, but even relatively ‘mild’ forms of early maternal deprivation can have 
significant short- and long-term behavioral and physiological consequences (Suomi, 
1997).  
 Similarly, maternally deprived females are more likely to exhibit neglectful and/or 
abusive treatment of their own offspring (Suomi, 1997). Natural variations in maternal 
licking/grooming (LG) in rat pups during the first week of life have been shown to alter 
gene expression, physiology and behavior of both male and female offspring (Caldji et 
al., 1998; Liu et al., 2000; Liu et al., 1997). Cross-fostering of offspring from high LG 
mothers to low LG mothers (and vice versa) has shown that the adult phenotype of 
these offspring can be influenced by quality of postnatal care (Francis et al., 1999a). 
These variations in maternal care are passed from one generation to the next, providing 
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a behavioral mechanism of inheritance of stress response and social behavior 
(Champagne and Curley, 2005). 
 Given the deficits in maternal care observed in INI/+ dams, we sought to 
determine what effects this rearing environment exerts, if any, on the behavior of 
offspring. We utilized a series of behavioral paradigms to investigate activity and anxiety-
related behaviors that may be present, both as a factor of the maternal environment and 
as a result of the introduced mutation.  
 
Experimental procedures 
 
 Unless otherwise indicated, animals used for these series of experiments were 
naïve male age-matched animals (12-14 weeks of age, n=10/genotype) generated by 
heterozygous mutant females mated to hemizygous mutant males (INI/+ x INI/Y) to 
generate +/Y and INI/Y male littermates raised by INI/+ dams. Where indicated, each 
group of experiments included wild-type males reared by wild-type dams as a control.  
Elevated-plus maze analysis of anxiety-related behavior 
 Elevated-plus maze experiments were conducted as described previously in 
chapter 4.  
 
Open Field 
 Open field experiments were performed as described previously with animals 
exposed to the open field for 100 minutes. See chapter 4. 
 
Light-Dark (emergence neophobia) 
 For assays of light-dark preference, open-field chambers were fitted with an 
acrylic insert (black walls and ceiling) to partition the chamber into an enclosed dark 
chamber and an open light chamber of equal size. Mice were placed in the center of a 
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brightly light chamber and permitted to freely pass between light and dark chambers 
during the duration of the five-minute assay. The total time spent in each chamber, in 
addition to the number of entries into each chamber, was recorded.  
 
Y-maze 
The Y-maze is a y-shaped apparatus in which the three arms were equal in 
length. Each arm consisted of clear, circular Plexiglas that was 30.5 cm long x 4.8 cm 
wide x 4.3 cm tall with the bottom of the Plexiglas tube removed so that the maze sat flat 
on a grey rubber surface. The end of one arm was removable for placement of mice into 
the maze. The arms of the maze joined in the center with each arm at a 120° angle from 
the next. Spatial cues were available to the mice during the testing. A videocamera was 
mounted overhead to record animal behavior. 
Each animal was placed into the apparatus for eight minutes and permitted to 
freely explore the maze. Two investigators, blind to genotype, recorded the order of 
entry into each of the arms, with an entry defined as all four paws entering into an arm of 
the maze. If an entry order discrepancy was present between the two investigators, the 
animal was then analyzed using the videotaped behavior. Spontaneous alteration 
behavior was defined as non-repetitive entry into each of the maze arms and number of 
total entries was also measured.  
 
Cocaine-Induced Locomotor Activity 
To assess changes in locomotor activity in response to cocaine, mice were 
placed in an open-field arena and movement was detected by a series of infrared beams 
as described in Chapter 4. Baseline activity was determined by administration of IP 
injections of saline, followed by assessment of locomotor activity for 2 hours per day for 
successive 3 days. On the 4th day, mice were treated (IP) with 10 mg/kg cocaine (Sigma) 
97 
 
or saline vehicle and returned to the open-field arena for 2 hours of testing. Following 
testing, mice were rapidly sacrificed and perfused as described earlier. Brains were 
removed and postfixed overnight at 4°C, then immersed in a series of sucrose (10%, 
20%, 30%) solutions and saved at 4°C for future studies.  
 
 
Results 
It is widely accepted that poor maternal environment can lead to long-term 
defects in offspring (Caldji et al., 1998; Francis et al., 1999b; Meaney, 2001). To 
characterize potential deficits in offspring, we performed behavioral analyses on male 
animals reared by wild-type and INI/+ dams and also included a cohort of wild-type 
reared wild-type male offspring.  
Open field 
To assess potential alterations in locomotor activity in offspring, we utilized an 
open field assay. When offspring were analyzed in an open-field, only INI/Y males 
reared by INI/+ dams displayed significant changes in activity. INI/Y males were initially 
hyperactive on the first two days of the test paradigm, but by the third day of testing, the 
total distance traveled by all animals was not significantly different regardless of their 
genotype or the genotype of the dams by which they were raised (Figure 38). 
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Figure 38: Open-field analysis of offspring locomotor activity. Activity behavior 
assessed by open-field analysis is presented for INI/Y mice (   ) and +/Y mice (◊) reared 
by INI/+ dams as well as +/Y mice reared by +/+ dams (●); the total distance traveled in 
100 minutes over three consecutive trial days is presented. (mean±SEM, n=10 for each 
genotype; *p<0.05 by one-way ANOVA). 
 
 
Elevated-plus maze 
The relationship between early life events and health in adulthood appears to be 
mediated by parental influences on the development of neural systems which underlie 
the expression of behavioral and endocrine responses to stress (Caldji et al., 1998; 
Francis et al., 1999a). To assess if poor maternal care resulted in anxiety-related 
behaviors for adult mice raised by INI/+ dams, we utilized the elevated-plus maze. 
Results from this analysis revealed that both wild-type and INI/Y mice raised by mutant 
dams spent significantly less time in the open arms of the maze and had less open arm 
entries that mice raised by wild-type dams (Figure 39), consistent with an increase in 
anxiety-related behavior as a consequence of deficits in maternal care.  
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Figure 39: Anxiety-related behavior is observed in mice raised by INI/+ mutant 
dams. Elevated plus maze analysis of anxiety-like behavior is presented for INI/Y (white) 
and +/Y (grey) mice reared by INI/+ dams as well as +/Y mice reared by +/+ dams 
(black); the total number of entries as well as entries into closed and open arms is 
presented (mean ± SEM, n=10 for each genotype; *:p<0.05, **: p<0.01, ***:p<0.001 by 
one-way ANOVA). 
 
 
Y-maze 
 The Y-maze takes advantage of the exploratory drive of rodents to investigate 
the newest areas of their environment. When animals from the selective breeding 
paradigm were subjected to the y-maze, animals reared by INI/+ dams make less total 
entries in the maze than animals reared by wild-type dams (Figure 40A). When we 
examine spontaneous alternation behavior, we find no differences between any of the 
genotypes (Figure 40B). 
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Figure 40: Activity and spontaneous alternation by offspring in the Y-maze. Y-
maze analysis of activity (a) and spontaneous alternatition (b) behavior is presented for 
INI/Y (white) and +/Y (grey) mice reared by INI/+ dams as well as +/Y mice reared by +/+ 
dams (black); the total number of entries (a) as well percent spontaneous alternation is 
presented (mean ± SEM, n=10 for each genotype; *:p<0.05 by one-way ANOVA). 
 
 
Light-dark exploration 
An additional behavioral measure of anxiety is light-dark exploration (emergence 
neophobia) in which an open field arena can be bisected into light and dark chambers. 
Traditionally, mice with increased anxiety-related behaviors will spend more time in the 
dark side of the chamber. In the light-dark exploration task, INI/Y mice reared by INI/+ 
dams traveled more total distance in the entire arena as compared to their wild-type 
littermates (Figure 41A). This increase in total distance is due to increased distance 
traveled in both the light and dark chambers. Despite this hyperactivity observed in both 
sides of the chamber, INI/Y animals spent less time in the light area of the arena (Figure 
41B) indicating increased anxiety-like states as well as hyperactivity. 
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Figure 41: Emergence neophobia behavior in +/Y and INI/Y animals. Emergence 
neophobia analysis of anxiety-like behavior is presented for INI/Y (white) and +/Y (black) 
mice reared by INI/+ dams; the total distance traveled (a) as well as percentage of total 
time spent in the light portion of the apparatus (b) is presented (mean ± SEM, n=10 for 
each genotype; *:p<0.05 by one-way ANOVA). 
 
 
Cocaine-induced locomotor activity 
 
 Cocaine administration in rodents typically results in increased spontaneous 
locomotor behavior and the expression of behavioral stereotypy. Discrete circuits within 
the CNS are proposed to play a role in each of these behaviors with striatal dopamine 
mediating stereotypy behaviors while locomotor activity is thought to be mediated by the 
nucleus accumbens (Kalivas and Stewart, 1991; Koob and Bloom, 1988; Pulvirenti et al., 
1991). Given the potential role of DA reward systems in the initiation and maintenance of 
maternal behaviors (Ferris et al., 2005; Stern and Keer, 1999), we sought to determine if 
offspring of wild-type and INI/+ displayed alterations in cocaine locomotor responses. 
Following a three day acclimation period, mice were assessed for their locomotor 
responses to cocaine and compared to a saline treated group of the same genotype. As 
expected saline-treated animals did not show any increase in activity over baseline. All 
cocaine injected animals did display increases in activity, but responses were dependent 
upon genotype. As a group, INI/+ reared offspring had greater increases in cocaine-
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induced locomotion than wild-type reared offspring (Figure 42). In addition to these 
observed changes in activity, INI/+-reared offspring also had increased stereotypic 
behaviors.  
 
 
 
Figure 36: Locomotor responses following a single dose of cocaine in offspring of 
+/+ and INI/+ dams. Open-field analysis is presented for locomotor responses following 
saline or cocaine treatment. The total distance traveled (as a percent change from 
baseline) is presented in fifteen minute bins (mean±SEM, n=5 for each genotype; p>0.05 
by one-way ANOVA). 
 
 
Discussion 
 
The experiments described in this chapter add further support to existing data 
underscoring the effects of maternal environment on the development and behavior of 
offspring. As a result of their deprived maternal environment, offspring of INI/+ dams 
display abnormalities in most behavioral paradigms examined irrespective of genotype, 
implicating rearing effects of INI/+ dams rather than the genotype of the offspring 
themselves. 
 We observe decreased levels of activity in both wild-type and mutant offspring of 
INI/+ dams in several behavioral paradigms including y-maze and elevated plus maze. 
Decreased activity in all of these paradigms is known to correlate with anxiety, 
suggesting a pervasive anxious phenotype in offspring of INI/+ dams. For traditional 
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measures of anxiety, we utilized the elevated plus maze and the emergence neophobia 
paradigm. EPM analyses revealed that offspring of INI/+ dams display remarkable 
anxiety-like traits including making less total entries and complete failure to enter the 
open arms of the maze (Figure 39). In the emergence neophobia paradigm, INI/Y mice 
spent less time in the open area of the field, also suggesting increased anxiety-like 
states in these animals (Figure 41B). Differences observed in spontaneous alternations 
within the Y-maze may indicate deficits in hippocampal memory as the animal may not 
recall which arms have been previously explored. Offspring of INI/+ dams make less 
total entries within the y-maze, indicating a decreased propensity to explore (and likely 
increased anxiety-like states); no differences were observed in spontaneous alternations 
suggesting that hippocampal memory is intact and these differences are not explained 
by a memory deficit (Figure 40). 
 Behavior of INI/+ and wild-type offspring diverge only with respect to baseline 
activity, environmental reactivity and magnitude of cocaine-induced hyperactivity. 
Measures of baseline activity reveal that offspring of INI/+ dams are typically 
hyperactive, though differences are observed depending on behavioral paradigm. In an 
open-field arena, INI/Y males raised by INI/+ dams are hyperactive when measured on a 
single day as observed in the emergence neophobia paradigm. This hyperactivity 
persists across longer trials (100 minutes) over several days (three), but by the third day 
INI/Y animals have similar levels of activity to wild-type littermates (Figure 38), 
suggesting that these animals are hyper-reactive to novel situations. 
 A cocaine-induced locomotor paradigm was utilized to determine if INI-mutant 
animals showed abnormal responses to the locomotor effects of a stimulant (cocaine) 
(Figure 42). While this experiment was statistically underpowered to detect any effects, 
we only observed hyperactive behavior in INI/Y offspring of INI/+ dams following 
repeated exposure to an open-field. As an entire group, INI/+ reared offspring displayed 
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greater increases in activity in response to cocaine administration. Since INI/Y mice 
have a higher baseline activity rate, their increased activity in response to cocaine 
parallels the increases seen in +/Y offspring of +/+ dams. Follow up studies using a 
larger sample size are needed to determine if cocaine differentially exerts its effects on 
offspring of +/+ and INI/+ dams. 
 Generalization of these findings is limited by the fact that 5HT2CRINI animals are 
currently maintained on a 129S6/SvEvTac background strain, a mouse strain that is 
suboptimal for behavioral assays due to previous observations indicating that this 
background strain displays increased levels of anxiety as compared to other strains 
(Bothe et al., 2004; Voikar et al., 2004). All behavioral studies should be repeated on 
animals that have been fully backcrossed to the C57BL/6J strain, a mouse strain widely 
used in mouse behavioral studies displays less anxiety-related traits (Bothe et al., 2004; 
Voikar et al., 2004) as well as more reliable responses to the locomotor effects of 
cocaine (Miner, 1997; Schlussman et al., 1998), before interpretations of 5HT2CRINI mice, 
relative to other mutant mouse lines, can be made. 
 Taken together, these data suggest that offspring of INI/+ dams are highly 
anxious. Since these behavioral alterations are observed in both +/+ and INI/Y 
littermates reared by INI/+ dams, these anxiety-related behaviors must be due to early 
maternal differences rather than effects resulting from the introduced INI mutation. 
These observations are consistent with existing data that neglectful maternal behavior 
promotes anxiety phenotypes in offspring (Caldji et al., 1998; Francis et al., 1999b). 
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CHAPTER VI 
 
 
SUMMARY AND FUTURE DIRECTIONS 
 
 
Summary 
  
RNA editing refers to a group of post-transcriptional modifications that involve 
base modification, substitution or deletion of RNA sequences. The editing process can 
create vast genomic diversity in the human transcriptome by generating multiple protein 
isoforms from a single genomic locus (Gott and Emeson, 2000). In mammals, A-to-I 
RNA editing has previously been shown to alter the amino acid coding potential of the 
mRNA, leading to functional changes within the encoded protein. In addition to modifying 
protein sequences, RNA editing can also alter the structure, stability, translation 
efficiency and alternative splicing patterns of edited transcripts (Bass, 2002; Gott and 
Emeson, 2000).  
Numerous lines of mutant mice have been generated to study the functional 
impact that RNA editing may have in vivo. The best characterized editing site, the Q/R 
site within transcripts encoding the GLUR2 subunit of the AMPA receptor, is edited to 
near completion in the postnatal brain (Sommer et al, 1991). Mice that express only the 
fully edited version of the protein (GluR2R) were generated and homozygous mutant 
mice appeared phenotypically and electrophysiologically normal (Kask et al., 1998). 
Conversely, mutant mice that express a modified GluR2 allele that cannot be edited 
(GluR2Q) die by P14-P21 due to seizures triggered by the increased permeability of the 
AMPA receptor to Ca2+ (Brusa et al., 1995). Taken together, these results suggest that 
RNA editing of the GLUR2 subunit of the AMPA receptor is required for normal function 
in the CNS. 
The Q/R site within transcripts encoding the GLUR5 subunit of kainate receptors 
also modulates Ca2+ permeability and channel conductance (Bernard and 
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Khrestchatisky, 1994; Kohler et al., 1993). Genetically modified mice that solely 
expressed the fully-edited version of this subunit (GluR5R) were generated to determine 
whether regulated editing at this site is necessary for normal CNS development and 
function. Heterozygous and homozygous mutant mice were viable and phenotypically 
normal; electrophysiologically there were no obvious consequences of expressing a fully 
edited GLUR5 subunit, suggesting that editing at this site is not essential for viability 
(Sailer et al., 1999). 
The Q/R site of the GLUR6 subunit of the kainate receptor also modulates Ca2+ 
permeability (Egebjerg and Heinemann, 1993) and may play a role in the modulation of 
synaptic transmission and seizure susceptibility (Bernard and Khrestchatisky, 1994). To 
address these functional questions, a mutant strain of mouse that solely expressed the 
non-edited version of GLUR6 was generated (Vissel et al., 2001). Homozygous mutant 
mice were viable and did not display any overt phenotypic differences, yet 
electrophysiogical analyses revealed that mutant mice displayed an increased 
susceptibility to kainate-induced seizures as well as enhancements in NMDA-
independent LTP in the perforant pathway (Vissel et al., 2001). These results suggest 
that RNA editing of the GLUR6 subunit leads to lowered seizure threshold and altered 
modulation of synaptic plasticity, and is therefore required for normal CNS function 
(Vissel et al., 2001). 
Mutant mice have also been generated to study both ADAR substrates and the 
ADAR enzymes themselves. Several lines of ADAR1 knockout mice have been 
produced. The first line revealed the most extreme phenotype, with embryonic lethality 
observed in chimeric animals (Wang et al., 2000a). Conditional knockouts of ADAR1 
were later developed using Cre-mediated recombination (Hartner et al., 2004; Wang et 
al., 2004), which lead to the survival of chimeric and heterozygous ADAR1-null mice. 
However, global ablation of ADAR1 expression resulted in embryonic lethality in 
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homozygous null animals (Hartner et al., 2004; Wang et al., 2004). Embryonic lethality 
occurred between E11 and E12.5 due to deficits in liver development and was 
characterized by hematopoietic failure, as well as widespread apoptosis in the heart, 
liver and vertebra, suggesting the involvement of ADAR1 in the development and 
function of these systems (Hartner et al., 2004; Wang et al., 2004). 
ADAR2 null animals have also been successfully generated with a normal 
Mendelian ratio at birth indicating that ADAR2 does not lead to embryonic lethality, 
however homozygous null mice died of seizures by P20 (Higuchi et al., 2000). Given the 
similar phenotype of ADAR2 null animals with that observed in mice unable to edit the 
Q/R site of the GLUR2 subunit of the AMPA receptor, it was suggested that editing of 
this site must be mediated by ADAR2 (Higuchi et al., 2000). In an attempt to rescue the 
phenotype of ADAR2 null animals, an edited GLUR2 allele(s) was introduced into these 
animals (Higuchi et al., 2000). ADAR2 null animals that expressed a single edited copy 
of GLUR2 had delayed lethality until P35 and null animals with 2 copies of edited 
GLUR2 appeared phenotypically normal (Higuchi et al., 2000), suggesting that the 
postnatal lethality observed in ADAR2 null animals is due to the loss of editing at the 
Q/R site of GLUR2 transcripts, highlighting the requirement for normal ADAR2 
expression and function (Higuchi et al., 2000). 
ADAR2 has been shown to edit its own pre-mRNA, suggesting an autoregulatory 
mechanism by which ADAR2 can modulate its expression as a means of controlling 
editing levels within the organism (Rueter et al., 1999). To test this hypothesis, a mutant 
strain of mouse was generated in which the conserved duplex structure (ECS) was 
disrupted with the potential for conditional ablation of ADAR2 autoediting (ΔECS) (Feng 
et al., 2006). Homozygous ΔECS were viable with no obvious phenotypic abnormalities; 
detailed analysis revealed that autoediting of ADAR2 was successfully ablated leading to 
an increase in ADAR2 protein in multiple tissues and increased levels of editing for 
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ADAR2 substrates (Feng et al., 2006). These results support the hypothesis that 
autoediting serves as a negative-feedback mechanism to modulate ADAR2 protein 
expression and function (Feng et al., 2006), yet the physiological consequences 
resulting from autoediting dysregulation have not yet been identified. 
The functional relevance of RNA editing for the 5HT2C receptor has been well-
characterized in vitro, but parallel studies in vivo were lacking. Analysis of 5HT dose-
response curves in transfected NIH-3T3 cells demonstrated that serotonergic agonists 
were 15- and 40-fold less potent when acting through the edited VSV and VGV receptor 
isoforms, respectively, suggesting that edited isoforms couple less efficiently to the 
intracellular signaling machinery (Burns et al., 1997; Niswender et al., 1998). 
Competition binding studies using human isoforms of the 5HT2C receptor revealed a 
guanine nucleotide-sensitive high-affinity state, only observed in the non-edited (INI) 
receptor, providing direct evidence that RNA editing generates 5HT2C receptor isoforms 
that differ in G-protein coupling efficiency (Niswender et al., 1999), affecting both basal 
activity and ligand potency (Herrick-Davis et al., 1999). 
To further characterize the role of RNA editing in vivo, we evaluated the 
developmental regulation of RNA editing and the editing enzymes, ADAR1 and ADAR2. 
By using complementary approaches, we demonstrate spatiotemporal regulation of 
expression patterns for ADAR1 and ADAR2 in the mouse forebrain. ADARs are 
expressed at low levels early in development and increase gradually during a 
developmental time course at both the mRNA and protein levels. Regionally, ADAR1 
mRNA displayed the lowest expression levels in the choroid plexus, cortex and 
hippocampus, and the highest levels in the thalamus (Figure 11A). Similarly, ADAR2 
mRNA expression levels are lowest in cortex and hippocampus, with increased 
expression in the thalamus (Figure 11B). We have also reported complete ADAR 
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colocalization with NeuN indicating that ADAR expression is restricted to neuronal 
populations (Figures 14 and 15).  
Additionally, we have determined the editing patterns of several known edited 
substrates throughout the developmental time course. In agreement with previous 
studies, we confirmed the nearly complete editing of the Q/R site of GLUR2 by E15 
(Figure 22B). Other substrates had low levels of editing at E15 and gradually increased 
throughout development. Exceptions to this pattern were the I/V site of Kv1.1 in which 
significant editing did not occur until after P0 and the 5 individual sites of the 5HT2C 
receptor. The D-site of the 5HT2C receptor was 50% edited at E15 and increased to 
maximal editing levels by P21; the remaining sites had relatively low editing at E15 and 
reached adult levels by P0 (Figure 22A). In adult animals, we investigated site-specific 
editing in several brain regions (choroid plexus, cortex, hippocampus, hypothalamus, 
olfactory bulb, striatum) using Pyrosequencing on individual cDNA clones. Editing 
patterns revealed a very similar pattern of 5HT2C receptor edited isoforms to that 
observed in rat with VNV representing the most predominate isoform in whole brain and 
the non-edited, INI, isoform representing only about 10% of total isoform expression 
(Table 1). 
Given the distinct expression patterns of the 5HT2C receptor editing isoforms in 
mouse brain, each with differing functional properties, we sought to determine the 
physiological role of RNA editing in vivo by generating a mutant strain of mouse that 
solely expressed the non-edited isoform of the 5HT2C receptor (5HT2CRINI). Mutant mice 
are viable and fertile with a normal Mendelian distribution observed. However, in INI-
expressing animals we observed decreases in receptor expression at the mRNA and 
protein levels. INI-mutant mice have a 30% decrease in mRNA (Figures 24 and 25), with 
a larger decrease observed for protein levels (Figure 28). Additionally, we observe a 
change in splicing pattern with 5HT2CRINI animals preferentially generating more non-
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functional RNA1 transcripts at the expense of full-length RNA2 transcripts (Figure 27). 
These results suggest a compensatory mechanism in 5HT2CRINI mice in response to the 
increased signaling capacity of the non-edited receptor. 
Despite alterations in receptor expression that may serve to balance enhanced 
signaling by decreasing 5HT2C receptor mRNA and protein levels, 5HT2CRINI animals are 
not phenotypically normal. The most overt phenotypes exhibited by INI-mutant animals 
were deficits related to maternal care. As compared to wild-type dams, heterozygous 
mutant dams fail to build nests for their young or retrieve their scattered pups into a 
common nest (Figures 36 and 37). This alteration in maternal environment leads to 
growth deficits (Figure 30) and altered behavior in offspring reared by heterozygous 
mutant dams (Figures 38-42).  
Offspring, regardless of genotype, reared by INI/+ dams display growth 
retardation as early as P7 (Figure 30A). Offspring maintain this 15-20% growth 
impairment throughout their lifespan and never successfully “catch up” to wild-type 
offspring reared by wild-type dams (Figure 30C and D). In addition to deficits in growth, 
offspring reared by INI/+ dams have increased anxiety-related behaviors, indicating that 
the early maternal environment provided by INI/+ dams transmits long term effects to 
offspring (Figures 39-42). 
Aberrant maternal care could not be explained by deficits in olfaction or novelty-
related tasks (Figure 35) or by alterations in mammary gland structures (Figure 31), but 
apparently by the altered signaling properties resulting from the sole expression of the 
non-edited (INI) 5HT2C receptor. This is underscored by the fact that treatment of newly 
postpartum dams with a single dose of a 5HT2C receptor inverse agonist, SB206553, 
restores near-normal pup retrieval behavior (Figure 37). 
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Future Directions 
 
 We have generated one of the first mutant strains of mice with altered 5HT2C 
receptor editing. Previous in vitro studies indicated that the INI isoform confers the 
greatest basal activity and agonist potency via enhanced G-protein coupling (Berg et al., 
2001; Herrick-Davis et al., 1999) and 5HT2CRINI animals exhibit phenotypes that would 
confirm these in vitro findings. 
Given that 5HT2CRINI animals have decreased mRNA expression, it would be 
compelling to assess mRNA stability. Primary neuronal cells could be cultured from 
cortex and hippocampus, treated with an inhibitor of transcription such as Actinomycin D 
(Beach and Ross, 1978; Chen et al., 1993; Sehgal et al., 1975; Singer and Penman, 
1972) and harvested at various timepoint to quantify mRNA and thus determine half-life. 
These methods are relatively toxic so alterative approaches (e.g. pulse-chase labeling) 
could also be considered. It may also be possible to assay mRNA stability within the 
animal, but typically the tissue of interest for these studies is usually the liver. Given that 
5HT2C receptor expression is limited to the CNS, these methods would have to be 
validated for analyses of brain transcripts and potential issues of toxicity would also need 
to be addressed.  
Similarly, 5HT2CRINI animals also have decreased receptor protein expression, 
most likely due to a decreased mRNA population from which to translate protein, but it is 
also possible that INI mutant animals have alterations in translation efficiency or 
decreased protein stability. Primary neuronal cultures could be treated with an inhibitor 
of translation such as cycloheximide, harvested at various time points and western blots 
could be performed for detection of protein levels.  
5HT2CRINI mice have altered 5HT2C receptor mRNA splicing; specifically, INI-
mutant animals have increased expression of the non-functional RNA1 isoform at the 
expense of decreased expression of full-length, fully-functional RNA2 isoform. While 
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mRNA splicing for this receptor is not fully understood, previous studies have shown that 
the snoRNA, MBII-52 (and its human ortholog, HBII-52) regulates alternative splicing of 
the 5HT2C receptor by binding to a silencing element within exon 5b and also promotes 
the formation of non-edited isoforms by masking a splicing silencer (Kishore and Stamm, 
2006). In mutant mice that only express the non-edited isoform, it is possible that MBII-
52 is directing the formation of RNA1 isoforms. Assays can be performed to determine 
MBII-52 expression in INI mice and elucidate whether MBII-52 is binding directly, 
thereby promoting RNA1 isoform formation. 
While this dissertation has focused on preliminary characterizations of maternal 
deficits using assays of nest building and pup retrieval, future studies should include a 
more detailed analysis of maternal behavior including time and position during nursing 
as well as assays of maternal aggression. While INI-mutant dams do not have 
alterations in prolactin or oxytocin mRNA within the pituitary and hypothalamus (Figure 
33), respectively, differences may still exist in circulating hormones that could potentially 
address some of these deficits in maternal behavior. 
Our attempts at cross-fostering were unsuccessful as wild-type offspring fostered 
to wild-type dams had decreased growth rates and altered behavior as compared to 
non-fostered wild-type offspring. Most likely these effects are due to the background 
strain of the animal, 129S6/SvEvTac, which is known to have higher levels of anxiety-
related behaviors as compared to other strains (Bothe et al., 2004; Voikar et al., 2004). 
Backcrossing studies are nearly complete to introduce the 5HT2CRINI mutation onto the 
C57BL/6J background and all behavioral assays should be repeated to confirm our initial 
findings.  
The most intriguing findings reported in this thesis are related to the identification 
of the potential mechanism underlying the deficits in maternal care observed in 
5HT2CRINI dams. Treatment of INI/+ dams with a single dose of a 5HT2C receptor inverse 
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agonist, SB206553, can rescue the observed retrieval deficits. Inverse agonists are 
highly effective in silencing the constitutive activity that some receptor subtypes exhibit; 
in vivo administration of SB206553 has been shown to increase basal DA release within 
nucleus accumbens and striatum (De Deurwaerdere et al 2004, Berg et al 2005). 5HT2C 
receptors are expressed on GABAergic interneurons within these brain regions (Figure 
43) (Eberle-Wang, 1997) and are responsible for serotonergic inhibition of mesolimbic 
DA activity (Di Giovanni et al., 2000; Gobert et al., 2000).  
 
 
Figure 43: Schematic representation of interactions between 5HT and DA 
pathways. a) 5HT neurons project from the raphe nuclei (pink) in the brainstem to two 
major DA pathways, the nigrostrital tract (purple) and the mesocortical tract (green). The 
nigrostriatal tract orginates in the substantia nigra and projects to the striatum (outlined 
in yellow). The mesocortical tract originates in the ventral tegmental area (VTA) of the 
midbrain and projects to cortical and limbic structures, including the nucleus accumbens 
(NAc, blue). These projections from the VTA to NAc are thought to mediate rewarding 
behaviors. b) Within the VTA, GABAergic interneurons (orange) express 5HT2C 
receptors and are able to modulate DA release within the NAc. 
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Given that mesolimbic DA release is critical for reinforcing and rewarding behaviors, 
including maternal care (Ferris et al., 2005), and mice lacking the 5HT2C receptor exhibit 
increased NAc DA levels and therefore enhanced sensitivity to the psychostimulant and 
reinforcing effects of cocaine (Rocha et al., 2002), we hypothesize that the DA reward 
system is blunted or hypoactive in 5HT2CRINI animals. The inverse agonist, SB206553, is 
able to increase basal DA release and therefore reinstate normal maternal behaviors. 
Future studies should focus on testing this hypothesis, including assays to determine if 
the DA reward system is intact (conditioned place preference and self-administration 
assays) as well as microdialysis measurements of DA release in the NAc and VTA under 
basal and drug-treated (agonist, antagonist, inverse agonist) conditions. 
This body of work helps to characterize the developmental regulation of RNA 
editing of the 5HT2C receptor and the phenotypic effects of editing loss, chiefly 
manifested by impaired maternal nurturing behavior. These data are in agreement with 
literature arguing that inadequacy of maternal care predicts phenotypic changes in the 
offspring (Caldji et al., 1998; Francis et al., 1999b) and our data suggest that an 
appropriately edited serotonin 2C receptor could effect expression of maternal behaviors 
through modulation of the mesolimbic DA reward pathway. Dissecting the intricacies of 
mother-child attachment has far-reaching implications, suggesting that potential 
pharmacological targets for the treatment of depressed or anxious mothers and 
underscoring the importance of psychosocial interventions to facilitate a nurturing infant 
environment. 
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